#  @Xtalks Xtalks Webinars Xtalks Webinars posts on X about ipo, hosted, how can, health the most. They currently have [------] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours. ### Engagements: [---] [#](/creator/twitter::136013508/interactions)  - [--] Week [---] +22% - [--] Month [-----] +153% - [--] Months [------] +14% - [--] Year [------] +106% ### Mentions: [--] [#](/creator/twitter::136013508/posts_active)  - [--] Week [--] +150% - [--] Month [--] +154% - [--] Months [---] +112% - [--] Year [---] +187% ### Followers: [------] [#](/creator/twitter::136013508/followers)  - [--] Week [------] -0.02% - [--] Month [------] -0.15% - [--] Months [------] -0.77% - [--] Year [------] -1.90% ### CreatorRank: [---------] [#](/creator/twitter::136013508/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [countries](/list/countries) [technology brands](/list/technology-brands) [cryptocurrencies](/list/cryptocurrencies) [travel destinations](/list/travel-destinations) [celebrities](/list/celebrities) [exchanges](/list/exchanges) [social networks](/list/social-networks) [currencies](/list/currencies) **Social topic influence** [ipo](/topic/ipo), [hosted](/topic/hosted), [how can](/topic/how-can), [health](/topic/health), [data](/topic/data), [ceo](/topic/ceo), [how to](/topic/how-to), [ai](/topic/ai), [novartis](/topic/novartis), [acquisition](/topic/acquisition) **Top accounts mentioned or mentioned by** [@soumya2390](/creator/undefined) [@ayeshar1202](/creator/undefined) [@verakovacevic3](/creator/undefined) [@cluepoints](/creator/undefined) [@miranabulsi123](/creator/undefined) [@bioclinica](/creator/undefined) [@iconplc](/creator/undefined) [@thecantang](/creator/undefined) [@stagebiocro](/creator/undefined) [@premierresearch](/creator/undefined) [@synteract](/creator/undefined) [@syneoshealth](/creator/undefined) [@omnicommsystems](/creator/undefined) [@dcchandel15](/creator/undefined) [@ppdcro](/creator/undefined) [@sydperelmutter](/creator/undefined) [@mercks](/creator/undefined) [@fortrea](/creator/undefined) [@abzenagroup](/creator/undefined) [@transperfect](/creator/undefined) **Top assets mentioned** [Novartis AG (NVS)](/topic/novartis) [Eli Lilly and Company (LLY)](/topic/eli-lilly) [Medtronic PLC (MDT)](/topic/medtronic) [AbbVie Inc (ABBV)](/topic/$abbv) [Sanofi (SNY)](/topic/sanofi) [Vera Therapeutics, Inc. (VERA)](/topic/$vera) [CVS Health Corp (CVS)](/topic/cvs) [GLP1 (GLP1)](/topic/glp1) ### Top Social Posts Top posts by engagements in the last [--] hours "@WuXiBiologics a global company with leading open-access biologics technology platforms today announced that it has successfully completed both a Pre-License Inspection (PLI) and a routine GMP inspection by the @US_FDA. #Regulatory #Biologics #FDA https://buff.ly/3xmKdAr https://buff.ly/3xmKdAr" [X Link](https://x.com/Xtalks/status/1385790627791654912) 2021-04-24T03:00Z 26.1K followers, [--] engagements "Gene editing company CRISPR Therapeutics is expanding its research manipulating #genetic code to treat disease entering into an agreement with private company Capsida Biotherapeutics to collaborate on therapies for two #neurodegenerative disorders. https://buff.ly/3vDYSF1 https://buff.ly/3vDYSF1" [X Link](https://x.com/Xtalks/status/1408130314468216832) 2021-06-24T18:30Z 26.1K followers, [--] engagements ".@Miro_Bio a #biotech company developing immune checkpoint agonists for #inflammatory and #autoimmunediseases is to be acquired by @GileadSciences for $405 million. Read more by @SaranyahKannuc1 to learn why Gilead will benefit from the acquisition. https://buff.ly/3p3HyZg https://buff.ly/3p3HyZg" [X Link](https://x.com/Xtalks/status/1557117014417842178) 2022-08-09T21:30Z 26.1K followers, [--] engagements "Register today Attendees will learn strategies to produce robust controlled-release tablets for the most challenging high-throughput commercial tableting conditions. #Formulation #DrugFormulation #Nitrosamines https://buff.ly/3TvXvWD https://buff.ly/3TvXvWD" [X Link](https://x.com/Xtalks/status/1643040689180008450) 2023-04-04T00:00Z 26.1K followers, [---] engagements "This weeks episode is about the Axonics Inc. non-drug implantable therapy for the treatment of bladder and bowel dysfunction and how AI can be used to study the side effects of drugs. Listen now: https://buff.ly/3M4EMOL https://buff.ly/3M4EMOL" [X Link](https://x.com/Xtalks/status/1655695000527687681) 2023-05-08T22:03Z 26K followers, [---] engagements "💊 @amicusrx1s Pombiliti + Opfolda is a new therapy for adults living with late-onset Pompe disease (#LOPD) who are not improving on their current enzyme replacement therapy. To learn more about the FDA approval for this rare disease read more at https://buff.ly/4a2jrQO https://buff.ly/4a2jrQO" [X Link](https://x.com/Xtalks/status/1730587896174817712) 2023-12-01T14:01Z 26.1K followers, [---] engagements "📰 Syneos Health has announced the appointment of Costa Panagos as its new CEO. Read more at by @AyeshaR1202 about Panagos who takes over from Colin Shannon the companys CEO following the companys acquisition by a consortium of private equity firms. https://buff.ly/3YgldsN https://buff.ly/3YgldsN" [X Link](https://x.com/Xtalks/status/1849557183056281966) 2024-10-24T21:02Z 26K followers, [---] engagements "❓ How can we reduce the burden of REMS programs on healthcare stakeholders Join Syneos Healths webinar to explore Health IT projects aimed at easing the load on prescribers and pharmacists with a more integrated automated REMS approach. Register now: https://buff.ly/3P1ZO2k https://buff.ly/3P1ZO2k" [X Link](https://x.com/Xtalks/status/1874802883943616538) 2025-01-02T13:00Z 26K followers, [---] engagements "Celltrions Avtozma has received FDA approval as a new biosimilar to Roches Actemra for indications including rheumatoid arthritis and COVID-19. Read more at by @AyeshaR1202 about Avtozma which is now the third approved Actemra biosimilar. https://buff.ly/4jIMDRX https://buff.ly/4jIMDRX" [X Link](https://x.com/Xtalks/status/1887206508384887157) 2025-02-05T18:27Z 26.1K followers, [---] engagements "The FDA has approved SpringWorks Therapeutics Gomekli (mirdametinib) for the treatment of the rare genetic disorder neurofibromatosis type [--] (NF1) in both adult and pediatric patients. Read more at by @AyeshaR1202. https://buff.ly/4jZ7hgz https://buff.ly/4jZ7hgz" [X Link](https://x.com/Xtalks/status/1890412956971589832) 2025-02-14T14:49Z 26K followers, [---] engagements "The FDA has approved Sanofis Merilog as the first rapid-acting insulin biosimilar. Merilog is a biosimilar to Novo Nordisks NovoLog and the third insulin biosimilar to receive approval to date. Read more at by @AyeshaR1202. https://buff.ly/4k6ERRZ https://buff.ly/4k6ERRZ" [X Link](https://x.com/Xtalks/status/1892227594130518163) 2025-02-19T14:59Z 26.5K followers, [---] engagements "❓ How can effective labeling strategies improve lab efficiency Join Computype and Thermo Fishers webinar to explore how reliable labeling can streamline accessioning and reduce errors. Register now: #Labware #LabelingStrategies #LabEfficiency https://buff.ly/3XkfD8T https://buff.ly/3XkfD8T" [X Link](https://x.com/Xtalks/status/1894827786340008442) 2025-02-26T19:12Z 26.5K followers, [---] engagements "Roche and Zealand Pharma are teaming up in a $5.3B deal to co-develop petrelintide a next-gen obesity therapy. With potential for best-in-class efficacy and a novel combo approach learn more about this major move by @soumya2390 at https://buff.ly/AhKmTKW https://buff.ly/AhKmTKW" [X Link](https://x.com/Xtalks/status/1901958557303554340) 2025-03-18T11:27Z 26K followers, [---] engagements "❓ How can AI-powered tools optimize pharmacovigilance workflows Join Syneos Healths webinar to discover how AI-driven case processing is transforming drug safety management. Register now: #AI #DrugSafety #Pharmacovigilance #Webinar #LifeSciences https://buff.ly/qjJwmkA https://buff.ly/qjJwmkA" [X Link](https://x.com/Xtalks/status/1908108396512858178) 2025-04-04T10:44Z 26K followers, [---] engagements "Novartiss newly approved Vanrafia (atrasentan) cut proteinuria by over 36% in a Phase III trial in patients with primary IgA nephropathy. Discover more about the oncedaily oral therapy in our latest article by @soumya2390 at https://buff.ly/CoHdaK5 https://buff.ly/CoHdaK5" [X Link](https://x.com/Xtalks/status/1910321673124856264) 2025-04-10T13:19Z 26.1K followers, [---] engagements "Terumo Neuro has received FDA premarket approval (PMA) for its latest Carotid Stent system which the company says is the first dual-layer micromesh carotid stent approved in the US. Read more at by @AyeshaR1202. https://buff.ly/03Fptjh https://buff.ly/03Fptjh" [X Link](https://x.com/Xtalks/status/1916859492026745003) 2025-04-28T14:18Z 26K followers, [---] engagements "In this episode hear from OS Therapies CEO Paul Romness about how the company is advancing innovative immunotherapies in cancers like osteosarcoma. Listen now at https://buff.ly/GLI4JWk https://buff.ly/GLI4JWk" [X Link](https://x.com/Xtalks/status/1918303215428178347) 2025-05-02T13:55Z 26K followers, [---] engagements "❓ How can bakeries meet rising consumer demands for healthier functional and sustainable products Join Brenntags webinar to explore egg replacements sugar reduction and clean label innovations. Register now: #BakingIndustry #FoodInnovation #Sustainability #Brenntag https://buff.ly/RA4OuiI https://buff.ly/RA4OuiI https://buff.ly/RA4OuiI https://buff.ly/RA4OuiI" [X Link](https://x.com/Xtalks/status/1927369744912458095) 2025-05-27T14:22Z 26.1K followers, [---] engagements "June [--] was the first-ever #FSGSAwarenessDay. Travere Therapeutics' #PlayItForwardFSGS campaign led by artists Brian Kennedy & David Rush celebrates creativity in the FSGS community and invites others to share their stories. Read more at #RareKidneyDisease #FSGS #PatientVoices #TravereTherapeutics. https://buff.ly/yDehMsh https://buff.ly/yDehMsh https://buff.ly/yDehMsh https://buff.ly/yDehMsh" [X Link](https://x.com/Xtalks/status/1933608177402064930) 2025-06-13T19:31Z 26K followers, [---] engagements "The FDA has approved Nuvation Bios Ibtrozi for advanced ROS1+ NSCLC. The drug shows strong intracranial efficacy and durable responses which could help the next-gen TKI shift the treatment landscape that is currently led by TKIs from Pfizer BMS and Roche. Read more at https://buff.ly/Nhdiq0R https://buff.ly/Nhdiq0R" [X Link](https://x.com/Xtalks/status/1935330822443184314) 2025-06-18T13:36Z 26K followers, [---] engagements "❓ Is your early phase oncology trial ready for FDAs Project Optimus Join Syneos Health's webinar with Wael Harb MD X.Q. Xue and Patrick Melvin as they explore how Project Optimus is reshaping early phase oncology trials. Learn how to design smarter trials that meet FDA expectations while reducing regulatory risk and accelerating development. Register now: #OncologyTrials #FDA #ClinicalTrials #DoseOptimization #SyneosHealth https://buff.ly/7kqzM92 https://buff.ly/7kqzM92" [X Link](https://x.com/Xtalks/status/1939689631848476981) 2025-06-30T14:17Z 26K followers, [---] engagements "argenx debuts two new Vyvgart Hytrulo TV ads focused on self-injection flexibility and personalized generalized myasthenia gravis (gMG) care. Explore more about these campaigns at by @soumya2390. #VyvgartHytrulo #argenx #gMG #MyastheniaGravis #AutoimmuneTreatment #TVAds #DTCA #SubcutaneousTherapy #PatientAutonomy #AtHomeTreatment #FcRnBlocker #SelfInjection https://buff.ly/FYi1E8P https://twitter.com/i/web/status/1949910082143080790 https://buff.ly/FYi1E8P https://buff.ly/FYi1E8P https://twitter.com/i/web/status/1949910082143080790 https://buff.ly/FYi1E8P" [X Link](https://x.com/Xtalks/status/1949910082143080790) 2025-07-28T19:09Z 26K followers, [---] engagements "With promising Phase III data gefurulimab joins the conversation on next-gen biologics in generalized myasthenia gravis (gMG). We explore the trial outcomes and more at by @soumya2390. #AstraZeneca #Alexion #Gefurulimab #MyastheniaGravis #gMG #Nanobody #PhaseIII #PREVAILtrial #Neurology #RareDisease #AutoimmuneDisease #FcRn #C5Inhibitor #Vyvgart https://buff.ly/X0OSaDq https://buff.ly/X0OSaDq https://buff.ly/X0OSaDq https://buff.ly/X0OSaDq" [X Link](https://x.com/Xtalks/status/1951356027212804576) 2025-08-01T18:55Z 26.1K followers, [---] engagements "PTC Therapeutics Sephience (sepiapterin) gets the FDA green light for treating all PKU subtypes. Learn how this oral therapy expands options for managing BH4-responsive PKU by @soumya2390 at #Phenylketonuria #PKU #Sepiapterin #BH4Pathway #RareDisease #OrphanDrugs #PTCTherapeutics #FDAApproval #DrugDevelopment #EnzymeTherapy #MetabolicDisorders https://buff.ly/dYbAtPS https://buff.ly/dYbAtPS https://buff.ly/dYbAtPS https://buff.ly/dYbAtPS" [X Link](https://x.com/Xtalks/status/1952322901643788762) 2025-08-04T10:57Z 26K followers, [---] engagements "Today were highlighting Xtalks Featured Community Member Dr. Marissa Halfin MD MBA Director of Clinical Informatics at Labcorp. With a strong focus on integrating AI and real-world evidence (RWE) generation into clinical research she is helping modernize how evidence is generated and used to advance patient care. Dive into her story at https://buff.ly/DwkvMOm https://buff.ly/DwkvMOm" [X Link](https://x.com/Xtalks/status/1957749138142949416) 2025-08-19T10:19Z 26K followers, [---] engagements "In this episode Galderma US VP Medical Affairs Dr. Bill Andriopoulos discusses innovations in dermatology to advance care for every skin story. Listen now at 🎙 https://buff.ly/dX6eh47 https://buff.ly/dX6eh47" [X Link](https://x.com/Xtalks/status/1963608909198799285) 2025-09-04T14:23Z 26.1K followers, [--] engagements "❓ How can clinical trials for rare respiratory diseases be faster and more effective Join Francis Jones Terri Denissen Alex Auais and Gino Pirri from Thermo Fisher Scientific to explore how AI real-world data and strategic trial design are overcoming challenges in idiopathic pulmonary fibrosis (IPF) and other rare respiratory diseases. Learn how innovations in patient recruitment retention and trial execution improve outcomes and accelerate development. Register now: #ClinicalTrials #RareDisease #PatientRecruitment #AIinHealthcare #ThermoFisher #PPD https://buff.ly/CQAOZx9" [X Link](https://x.com/Xtalks/status/1965725216509690279) 2025-09-10T10:33Z 26.1K followers, [---] engagements "The FDA has approved Inluriyo (imlunestrant) an oral estrogen receptor antagonist for adults with ER+/HER2 ESR1-mutated advanced breast cancer. Learn about the trial data in our latest article at by @soumya2390. #Inluriyo #Imlunestrant #EliLilly #FDAApproval #BreastCancer #MetastaticBreastCancer #AdvancedBreastCancer #ERPositive #HER2Negative #ESR1Mutation #Oncology https://buff.ly/t8y63uM https://buff.ly/t8y63uM https://buff.ly/t8y63uM https://buff.ly/t8y63uM" [X Link](https://x.com/Xtalks/status/1973425438178398608) 2025-10-01T16:31Z 26.1K followers, [---] engagements "Were excited to share our video highlights from the @kpmorgangroup 9th Annual Operational Excellence in Clinical Trials (OECT) Summit in Toronto As the official Media Partner Xtalks was proud to capture key discussions on regulatory updates patient recruitment data quality and the future of clinical research. A special thanks to the clinical research experts who joined Xtalks for video interviews at the Summit: Tania Azad Global Program Director Late Phase Clinical Operations Alexion Pharmaceuticals Andrea Bastek PhD VP Market Strategy Florence Healthcare Kevin Lin MBA MSc Director Innovative" [X Link](https://x.com/Xtalks/status/1974114995198673351) 2025-10-03T14:11Z 26.1K followers, [--] engagements "Healthcare mergers and acquisitions in [----] continue to reshape the industry from hospital and behavioral health integrations to AI-powered platforms and payer-provider partnerships. Explore the latest deals transforming care delivery financing and digital health by @soumya2390 at #HealthcareMergers #HealthcareAcquisitions #HealthcareM&A #HealthcareDeals #HealthcareIndustry #HealthcareInnovation #HealthcareTrends #HospitalMergers https://buff.ly/vDiO2uS https://buff.ly/vDiO2uS" [X Link](https://x.com/Xtalks/status/1975937830674108559) 2025-10-08T14:54Z 26.1K followers, [---] engagements "❓ How can we accelerate pediatric clinical trials in oncology and hematology Join Thermo Fisher Scientific for a webinar with Charity Schuller PharmD MS RAC Mariana Burin MD Marcie Weil MD Sheree Gilmore and Sush Sankpal MD to explore strategies for overcoming enrollment challenges regulatory hurdles and equity gaps in pediatric cancer trials. Learn how innovative approaches in gene and cellular therapies are shaping the next generation of pediatric clinical research. Register now: #PediatricTrials #OncologyResearch #Hematology #ClinicalTrials #ThermoFisherScientific https://buff.ly/TcSX5RF" [X Link](https://x.com/Xtalks/status/1978403528910471221) 2025-10-15T10:12Z 26.1K followers, [--] engagements "❓ How can patient recruitment and site support reduce trial dropout Join SubjectWell for a webinar with Samantha Schmidt Richard Towne and Stacia Wilson to explore how optimizing the patient journey and site support can improve retention and trial success. The discussion will highlight real-world site challenges best practices for integrated patient and site support and strategies to maintain engagement during periods when sites are slower such as holidays. Register now: #ClinicalTrials #PatientRecruitment #TrialRetention #PatientExperience #SubjectWell https://buff.ly/HPPditr" [X Link](https://x.com/Xtalks/status/1979132069117575652) 2025-10-17T10:27Z 26.1K followers, [--] engagements "🚀 How can early medical information planning improve biotech product launch success Join Thermo Fisher Scientific for a webinar with Graham Harding and Dominique Van Hoese on how biotech teams can use medical information as a strategic driver during launch preparation not just a compliance requirement. The session will cover how proactive medical information strengthens cross-functional alignment mitigates risk supports scalability and enhances customer experience. Register now: #BiotechLaunch #MedicalInformation #RegulatoryStrategy #LifeSciences #ThermoFisherScientific" [X Link](https://x.com/Xtalks/status/1980586156099096602) 2025-10-21T10:45Z 26.1K followers, [---] engagements "❓ How can regulatory teams accelerate document generation without compromising security or accuracy Join ZYLIQ for a webinar with Mark Pittman to explore how closed-loop generative AI (Gen-AI) is reshaping regulatory writing. Discover how secure purpose-built AI systems can streamline the creation of safety narratives clinical study reports and other critical documents while maintaining full data protection and compliance. Register now: #RegulatoryWriting #AIinLifeSciences #ClinicalTrials #Automation #ZYLIQ https://buff.ly/whrxmjP https://buff.ly/whrxmjP" [X Link](https://x.com/Xtalks/status/1980982716809003019) 2025-10-22T13:00Z 26.1K followers, [--] engagements "Keytruda Qlex brings a subcutaneous version of pembrolizumab to [--] solid tumor indications with the same efficacy and one- to two-minute administration. Our latest article breaks down trial data and more at by @soumya2390. #KeytrudaQlex #Merck #FDAApproval #Immunotherapy #CancerCare #Oncology #CheckpointInhibitor #PD1 #Pembrolizumab #SubcutaneousInjection #Biopharma https://buff.ly/fKBM1c1 https://buff.ly/fKBM1c1 https://buff.ly/fKBM1c1 https://buff.ly/fKBM1c1" [X Link](https://x.com/Xtalks/status/1981410985018540427) 2025-10-23T17:22Z 26.1K followers, [---] engagements "❓ How can precision medicine and patient-centric trial design solve the challenges of clinical research for older adults with neurological diseases Join Thermo Fisher Scientific Inc. for a critical webinar featuring Panos Papanastasopoulos Debra Schaumberg ScD OD MPH John Hamlet Sabine Krofczik-Wilhelm PhD and Alberto Lled MD PhD. They will explore how sub-classifying complex conditions with disease-specific biomarkers and integrating the real-world needs of aging populations can make trials more precise and equitable especially for advanced therapies like cell and gene therapies. Register" [X Link](https://x.com/Xtalks/status/1983172988707979401) 2025-10-28T14:04Z 26.1K followers, [---] engagements "❓ Are slow planning cycles fragmented data and manual processes hindering your clinical trial delivery Join Tim Mudric and Dave Hiltbrand from Thermo Fisher Scientific to explore how Artificial Intelligence (AI) is transforming trial operations. Learn how prioritizing interoperable systems and collaboration can help your organization fully leverage AIs potential for operational excellence. Broadcast [--] (EMEA): 2:30 PM GMT / 3:30 PM CET Broadcast [--] (North America): [--] PM EST / [--] AM PST #ClinicalTrials #ArtificialIntelligence #AIDriven #DigitalTransformation #ClinicalResearch" [X Link](https://x.com/Xtalks/status/1983551628981551363) 2025-10-29T15:08Z 26.1K followers, [--] engagements "@M4Knicks Eric Robbibaro shares how continuous conductivity monitoring goes beyond compliance: it protects patients improves efficiency and supports sustainability in pharma manufacturing. Watch the Spotlight video and read the full article at 🎙 #PharmaceuticalManufacturing #DrugManufacturing #Conductivity #Compliance #LifeSciences #Biopharma #XtalksSpotlight #M4Knick https://buff.ly/FI8MWYo https://buff.ly/FI8MWYo https://buff.ly/FI8MWYo https://buff.ly/FI8MWYo" [X Link](https://x.com/Xtalks/status/1983839855550271628) 2025-10-30T10:14Z 26.1K followers, [--] engagements "Waves of layoffs continue in pharma and biotech this year. From Moderna and Novo Nordisk to Genentech and BlueRock Therapeutics [----] has brought sweeping workforce reductions across the life sciences sector. Read more #PharmaLayoffs #BiotechLayoffs #Layoffs https://buff.ly/EPFTyMG https://buff.ly/EPFTyMG https://buff.ly/EPFTyMG https://buff.ly/EPFTyMG" [X Link](https://x.com/Xtalks/status/1985372103386828919) 2025-11-03T15:42Z 26.1K followers, [--] engagements "🔁 Friday Rewind with Xtalks From sleep health campaigns to AI-powered acquisitions and new nonhormonal options for menopause treatment heres what moved the week. 😴 OSA Highlight: Lilly x Shaq Team Up on Awareness See the campaign: 📊 Poll: Which Emerging Tech Will Reshape Trials by [----] Cast your vote: 🤝 Thermo Fisher to Acquire Clario for $9.4B Scan the deal terms: 🧪 Saliva-Based Oral HPV Test Debuts Check how it works: 🌸 Bayers Lynkuet Enters US Menopause Market (Nonhormonal) Compare options: Life Sciences Central: A New Canada-Wide Pathway Explore the new hub: 🧬 Blenrep Combo" [X Link](https://x.com/Xtalks/status/1985372445654585616) 2025-11-03T15:44Z 26.1K followers, [--] engagements "Major pharma and biotech M&As are continuing into the latter half of [----] with big moves from big players like Thermo Fisher Novartis and Eli Lilly this month. Find out about the latest pharma deals at #PharmaMergersAndAquisitions #PharmaAcquisitions #BiotechAcquisitions #PharmaDeals https://buff.ly/WVl3qVu https://buff.ly/WVl3qVu https://buff.ly/WVl3qVu https://buff.ly/WVl3qVu" [X Link](https://x.com/Xtalks/status/1985388755373474028) 2025-11-03T16:49Z 26.1K followers, [--] engagements "Learn from Dr. Rebecca Abram PhD Director of Global Strategic Technical Marketing at FUJIFILM Biotechnologies about the future of conjugation and PEGylation in biologics with advancements focused on enhancing drug efficacy and reducing immunogenicity. Read more at https://buff.ly/rKy0dgU https://buff.ly/rKy0dgU" [X Link](https://x.com/Xtalks/status/1985438870226231567) 2025-11-03T20:08Z 26.1K followers, [---] engagements "Novo Nordisk has launched a bidding war with Pfizer for obesity biotech Metsera. The showdown is underway as both pharma giants race to expand their GLP-1 pipelines. Read more at #ObesityDrugs #MergersAndAcquisitions #NovoNordisk #Pfizer https://buff.ly/gMm2oEa https://buff.ly/gMm2oEa" [X Link](https://x.com/Xtalks/status/1985781555847975165) 2025-11-04T18:49Z 26.1K followers, [---] engagements "Join Ian Brown PhD from FUJIFILM Biotechnologies to learn how biopharma companies can implement 'Acceleration Levers' to reduce delays and optimize timelines in late-phase chemistry manufacturing and controls (CMC) programs for therapeutic proteins. In this webinar Ian will discuss strategies to streamline CMC activities across mammalian and microbial systems define what an acceleration lever is and explore key approaches for improving efficiency and success in therapeutic protein development. Register here: #CMC #Biopharma #TherapeuticProteins #ProcessDevelopment #AccelerationLevers" [X Link](https://x.com/Xtalks/status/1986040073356189759) 2025-11-05T11:57Z 26.1K followers, [---] engagements "Amgens new Otezla TV ad features a karaoke-night scenario to highlight the social impact of plaque psoriasis with a focus on quality of life earlier-stage treatment options and patient empowerment. Read more at #PsoriasisAwareness #Dermatology #PharmaMarketing #PatientCentricity #Otezla #Amgen https://buff.ly/GVkpGi6 https://buff.ly/GVkpGi6 https://buff.ly/GVkpGi6 https://buff.ly/GVkpGi6" [X Link](https://x.com/Xtalks/status/1986558782940254573) 2025-11-06T22:18Z 26.1K followers, [---] engagements "Eli Lilly and Novo Nordisk have struck deals with the Trump administration to reduce the monthly costs of GLP-1 weight loss medications which will be available through the new TrumpRx platform and expanded Medicare/Medicaid coverage. Read more at #DrugPricing #DrugPriceNegotiations #GLP1Drugs #ObesityDrugs #EliLilly #NovoNordisk https://buff.ly/pbPaR3Y https://buff.ly/pbPaR3Y https://buff.ly/pbPaR3Y https://buff.ly/pbPaR3Y" [X Link](https://x.com/Xtalks/status/1986900841748430952) 2025-11-07T20:57Z 26.1K followers, [---] engagements "Galdermas Dr. Bill Andriopoulos shares how clinical innovation long-term data and patient perspectives are transforming dermatological research and care in this Xtalks Clinical Edge interview. Read here: #XtalksClinicalEdge #ClinicalResearch #ClinicalTrials #Dermatology #Skin #AtopicDermatitis #Eczema https://buff.ly/NJBtpIp https://buff.ly/NJBtpIp https://buff.ly/NJBtpIp https://buff.ly/NJBtpIp" [X Link](https://x.com/Xtalks/status/1987840170217845125) 2025-11-10T11:10Z 26K followers, [--] engagements "Hear from Sara Bursomanno PhD and Chantale Julien from Novo as they tackle the critical issue of ensuring compliance and high performance using animal-free raw materials in CGT manufacturing. Discover validated recombinant solutions that meet stringent regulatory requirements and significantly boost key metrics like AAV titer and cell viability. Don't miss this opportunity to optimize your workflow and ensure product consistency and patient safety. Register now: #CellAndGeneTherapy #AnimalFree #CGTManufacturing https://buff.ly/AJ2Z3px https://buff.ly/AJ2Z3px" [X Link](https://x.com/Xtalks/status/1987845994055111118) 2025-11-10T11:33Z 26.1K followers, [--] engagements "With facilities and equipment designed for fast adaptability learn how FUJIFILM Biotechnologies can scale manufacturing operations in response to both product and market requirements whether by increasing capacity or shifting production strategies. Read more at #Biologics #Biomanufacturing #Biopharma https://buff.ly/mJRB2pa https://buff.ly/mJRB2pa" [X Link](https://x.com/Xtalks/status/1987890603976220802) 2025-11-10T14:30Z 26.1K followers, [--] engagements "Palo Alto California biotech Evommune is set to bring fresh momentum to chronic inflammation research. The $150M IPO will advance oral and injectable therapies that target diseases like urticaria and dermatitis. Learn more at by @soumya2390. #EvommuneIPO #InflammationResearch #AtopicDermatitis #BiotechNews #Immunology https://buff.ly/wqbZUTi https://buff.ly/wqbZUTi https://buff.ly/wqbZUTi https://buff.ly/wqbZUTi" [X Link](https://x.com/Xtalks/status/1987893736345313568) 2025-11-10T14:42Z 26.1K followers, [--] engagements "Pfizer has lost its court bid to block Novo Nordisks counteroffer for the obesity drug biotech. Read more at #Pfizer #NovoNordisk #Metsera #ObesityDrugs #PharmaLawsuit https://buff.ly/eelIzJk https://buff.ly/eelIzJk" [X Link](https://x.com/Xtalks/status/1987894269097508953) 2025-11-10T14:45Z 26.1K followers, [--] engagements "Uncover the emerging trends driving the future of cancer care with Dr. Jozsef Palatka MD Dr. Rob Berg MD PhD and Marek Rombel from Syneos Health. Learn which cutting-edge treatment modalities from evolving immuno-oncology to next-wave Antibody-Drug Conjugates (ADCs) are capturing oncologists' attention and reshaping the standard of care. Register to gain insights on how new clinical signals influence commercialization trial design and pipeline prioritization strategies: #Oncology #ClinicalTrials #DrugDevelopment https://buff.ly/VggxfeE https://buff.ly/VggxfeE" [X Link](https://x.com/Xtalks/status/1988563208840306850) 2025-11-12T11:03Z 26K followers, [---] engagements "For millions dry eye disease feels like having an eyelash in your eye every hour of every day with no relief. Elizabeth Jeffords CEO of Iolyx Therapeutics shares how understanding patient experience and autoimmune drivers is reshaping treatment approaches for this overlooked condition. Read more in this Xtalks Clinical Edge interview at by Mohammad Ali. #Ophthalmology #DryEyeDisease #XtalksClinicalEdge #IolyxTherapeutics #ClinicalResearch https://buff.ly/52Y0kQb https://buff.ly/52Y0kQb" [X Link](https://x.com/Xtalks/status/1988567708443488265) 2025-11-12T11:21Z 26.1K followers, [--] engagements "New Phase III data spotlight Mercks enlicitide decanoates once-daily oral approach to LDL-C reduction. Our article unpacks key lipid results and what comes next for this investigational PCSK9 inhibitor at by @soumya2390. #Merck #Cholesterol #Hypercholesterolemia #CardiovascularHealth #PCSK9 https://buff.ly/9lcOTec https://buff.ly/9lcOTec https://buff.ly/9lcOTec https://buff.ly/9lcOTec" [X Link](https://x.com/Xtalks/status/1988987047269326871) 2025-11-13T15:07Z 26.1K followers, [---] engagements "Recent weeks brought more workforce shifts in medtech with Olympus Abbott Medtronic and Philips all announcing job cuts. See whos been added to our Medtech Layoffs [----] roundup by @soumya2390 at #MedTechLayoffs #MedicalDevices #MedTechNews #WorkforceTrends https://buff.ly/TEhtTHd https://buff.ly/TEhtTHd https://buff.ly/TEhtTHd https://buff.ly/TEhtTHd" [X Link](https://x.com/Xtalks/status/1988987250105835904) 2025-11-13T15:08Z 26.1K followers, [--] engagements "@clinicaltrialON [----] brought together researchers regulators industry leaders and patients to reimagine efficiency ethics and access in Canadas clinical trial ecosystem. Xtalks spoke with Dr. PJ Devereaux Susan Marlin Matt Westmore Ramy Nassar Dr. Sowmya Viswanathan and Donna Janzen who shared their perspectives on navigating and driving efficient patient-centered research in Canada. Read our full post-event recap @soumya2390 at A special thank you to Elise Johnson and everyone at Clinical Trials Ontario for organizing #CTO2025. #ClinicalTrialsOntario2025 #ClinicalResearch #AIinHealthcare" [X Link](https://x.com/Xtalks/status/1989006706773254269) 2025-11-13T16:25Z 26.1K followers, [--] engagements "Eli Lilly has partnered with Tan France from Netflix's Queer Eye on its new Changing the Thread Collection Zepbound campaign that weaves together fashion storytelling and science to challenge obesity stigma. Read more at #EliLilly #Zepbound #TanFrance #ObesityAwareness #PatientVoice #PharmaMarketing https://buff.ly/i0ey1HH https://buff.ly/i0ey1HH https://buff.ly/i0ey1HH https://buff.ly/i0ey1HH" [X Link](https://x.com/Xtalks/status/1989081788010955083) 2025-11-13T21:23Z 26K followers, [---] engagements "Vote and see results in our latest Xtalks Life Science Poll: What technology do you think will transform clinical trials by [----] the most AI decentralized trial platforms wearables or real-world data (RWD) integration Vote and see results here: #ClinicalTrials #DigitalHealth #Pharma #Biotech #DCT #RWD #Wearables https://buff.ly/KAdRX44 https://buff.ly/KAdRX44 https://buff.ly/KAdRX44 https://buff.ly/KAdRX44" [X Link](https://x.com/Xtalks/status/1989299280054497412) 2025-11-14T11:48Z 26.1K followers, [---] engagements "Gain insights into addressing the complexities of large-scale cGMP viral vector manufacturing while meeting required quality standards with FUJIFILM Biotechnologies. Read more at #Biologics #CGT #CellandGeneTherapy #ViralVectors https://buff.ly/lpTYusa https://buff.ly/lpTYusa" [X Link](https://x.com/Xtalks/status/1990427324668318087) 2025-11-17T14:30Z 26.1K followers, [---] engagements "Register now to join Dr. John A. Karas Dr. Linda Haugaard-Kedstrm and Samuel J. Paravizzini PhD Candidate from PolyPeptide Group for a deep dive into advanced solid-phase peptide synthesis (SPPS) strategies. They will explore how innovative backbone protecting groups can overcome chain insolubility and aggregation issues that hamper yield and lead to inseparable deletion impurities. Sign up to learn the state-of-the-art methods for improving synthetic efficiency and product quality in complex peptide manufacturing: #PeptideSynthesis #SPPS #PeptideChemistry https://buff.ly/GcIDyxh" [X Link](https://x.com/Xtalks/status/1990825055647850834) 2025-11-18T16:50Z 26.1K followers, [--] engagements "Explore cutting-edge strategies for tackling peptide degradation with Elizabeth Denton PhD and Caroline Proulx PhD from Biotage. They will reveal how replacing the alpha carbon to create azapeptides alters conformation and facilitates the creation of large libraries overcoming common degradation challenges in drug design. Register to gain critical insights into new synthesis techniques and address the real-world difficulties of automated complex peptide chemistry workflows: #DrugDesign #Azapeptides https://buff.ly/cMq99Jw https://buff.ly/cMq99Jw" [X Link](https://x.com/Xtalks/status/1990885128655057368) 2025-11-18T20:49Z 26.1K followers, [---] engagements "Learn how bioinformatics contributes to in silico manufacturability assessments by Arghya Barman from FUJIFILM Biotechnologies. Read more at #Bioinformatics #Biologics #Biomanufacturing #Biopharma https://buff.ly/t4OZVRc https://buff.ly/t4OZVRc" [X Link](https://x.com/Xtalks/status/1992964030953058515) 2025-11-24T14:30Z 26.1K followers, [---] engagements "Join Dr. Sayna Norouzi Dr. Hannah Troutman and Sarah Dixon Stump for a webinar hosted by Thermo Fisher Scientific Inc to learn how polycystic kidney disease (PKD) clinical trials are shaping the future of ADPKD treatment. They will explore the clinical landscape factors to consider for clinical trials and emerging therapeutic targets like serum proteomics and ciliopathies. Register now to gain essential insights into addressing the urgent need for new effective treatments for this leading cause of genetic kidney failure: #PKD #ADPKD #ClinicalTrials https://buff.ly/MNz3IEt" [X Link](https://x.com/Xtalks/status/1992994792469381622) 2025-11-24T16:32Z 26.1K followers, [--] engagements "The FDA has approved Kyowa Kirin and Kura Oncologys jointly developed menin inhibitor Komzifti for relapsed or refractory NPM1-mutated AML. The approval comes just a month after Syndax Pharma's Revuforj was approved as the first-in-class menin inhibitor in the indication. Read more at #AcuteMyeloidLeukemia #AML #Hematology #PrecisionMedicine #Pharma #OncologyDrugs https://buff.ly/Szm6hLa https://buff.ly/Szm6hLa" [X Link](https://x.com/Xtalks/status/1993016268971024512) 2025-11-24T17:58Z 26.1K followers, [---] engagements "Were thrilled to celebrate and acknowledge the professionals driving innovation research and impact across life sciences in our next group of Xtalks Featured Community Members: Ankur Dnyanmote PhD Medical Writer Thermo Fisher Scientific Charles Legg Chair Global Advisory Board The Health Pals Company Giselle Della Rosa MSc Epidemiologist ACUMAR Per Rigler PhD Product Manager Bhlmann Laboratories AG Shazia Khan MSc Bioinformatician Life Science Researcher and Advocate for Women in STEM Srividya Narayanan MDS MS SaMD Regulatory Researcher Freyr Solutions Meet them all at and learn how to apply" [X Link](https://x.com/Xtalks/status/1993325565063975423) 2025-11-25T14:27Z 26K followers, [--] engagements "Unify your fragmented data and drive precision across the pharma value chain with Skye Hodson PhD and Ritupriya Yamujala in this webinar hosted by Citeline. They will demonstrate how a single connected ecosystem blending clinical RWE and market data augmented by trustworthy AI uncovers hidden patterns and accelerates critical decisions. Register now for the blueprint on optimizing protocol design accelerating recruitment and strengthening market forecasting from pipeline to patient: #PharmaData #TrustworthyAI #ClinicalTrials https://buff.ly/IijrRB1 https://buff.ly/IijrRB1" [X Link](https://x.com/Xtalks/status/1993333664302739602) 2025-11-25T14:59Z 26.1K followers, [--] engagements "FibroBiologics CEO Pete OHeeron and CSO Dr. Hamid Khoja share how fibroblast-based therapies may unlock new possibilities for immune modulation wound healing and longevity. Read more in this Xtalks Clinical Edge interview at by @VeraKovacevic3. #XtalksClinicalEdge #FibroBiologics #Fibroblasts https://buff.ly/I5jEn9O https://buff.ly/I5jEn9O https://buff.ly/I5jEn9O https://buff.ly/I5jEn9O" [X Link](https://x.com/Xtalks/status/1993638876653453555) 2025-11-26T11:12Z 26.1K followers, [---] engagements "The FDA has approved Novartis intrathecal SMA gene therapy Itvisma expanding gene therapy access for both pediatric and adult patients. Read more at including its $2.59M list price and multibillion-dollar peak sales projections. #GeneTherapy #RareDisease #SMA #Novartis https://buff.ly/5gLnKbI https://buff.ly/5gLnKbI https://buff.ly/5gLnKbI https://buff.ly/5gLnKbI" [X Link](https://x.com/Xtalks/status/1993708363943641391) 2025-11-26T15:48Z 26.1K followers, [---] engagements "In this episode hear from respiratory disease researcher and severe asthma expert Dr. Andrew Menzies-Gow from AstraZeneca about the latest innovations in respiratory and immunology drug development. Listen now at 🎙 https://buff.ly/DYVwKEn https://buff.ly/DYVwKEn" [X Link](https://x.com/Xtalks/status/1993756095332966763) 2025-11-26T18:57Z 26.1K followers, [--] engagements "From AI-enabled pre-screening to ultra-compact wearables and adaptive Phase III designs clinical trials evolved fast in [----]. Heres how these shifts are setting the tone for clinical trial trends in [----] at by @soumya2390. #ClinicalTrials2026 #DecentralizedTrials #DigitalBiomarkers #RWE #LifeSciences https://buff.ly/j7PWZvE https://buff.ly/j7PWZvE https://buff.ly/j7PWZvE https://buff.ly/j7PWZvE" [X Link](https://x.com/Xtalks/status/1993756835635978428) 2025-11-26T19:00Z 26.1K followers, [--] engagements "Navigate the inevitable disruptions in open claims data with Ramachandra (Ram) Bendre and Stephen Bielecki in this webinar hosted by ICON. They will demonstrate how thoughtful proactive management of these powerful datasets is essential for life sciences organizations to preserve analytical value and maintain a strategic advantage. Register now to learn how to anticipate interpret and adapt to shifts in open-sourced data with confidence: #ClaimsData #LifeSciences #DataStrategy https://buff.ly/UHlsmFW https://buff.ly/UHlsmFW" [X Link](https://x.com/Xtalks/status/1994007830567800973) 2025-11-27T11:38Z 26.1K followers, [--] engagements "Join Dr. Sayna Norouzi Dr. Hannah Troutman and Sarah Dixon Stump for a webinar hosted by Thermo Fisher Scientific Inc to learn how polycystic kidney disease (PKD) clinical trials are shaping the future of ADPKD treatment. They will explore the clinical landscape factors to consider for clinical trials and emerging therapeutic targets like serum proteomics and ciliopathies. Register now to gain essential insights into addressing the urgent need for new effective treatments for this leading cause of genetic kidney failure: #PKD #ADPKD #ClinicalTrials https://buff.ly/MNz3IEt" [X Link](https://x.com/Xtalks/status/1994060520169623662) 2025-11-27T15:07Z 26K followers, [---] engagements "Novo Nordisks Phase III evoke trials tested oral semaglutide in early Alzheimers disease. The drug did not slow clinical decline over two years. In our article we unpack the trial results safety findings and more at by @soumya2390. #NovoNordisk #AlzheimersDisease #Semaglutide #Neuroscience https://buff.ly/wmKeBuO https://buff.ly/wmKeBuO https://buff.ly/wmKeBuO https://buff.ly/wmKeBuO" [X Link](https://x.com/Xtalks/status/1994463248205095113) 2025-11-28T17:47Z 26.1K followers, [---] engagements "Gain insights from Michael Baker from FUJIFILM Biotechnologies about how expertise in oncolytic virus (OV) production cell culture and validation-level analytics can be hugely advantageous for OV developers looking to bring their products to market. Read more at #OncolyticVirus #OncolyticVirusTherapy #CellCulture #CellandGeneTherapy https://buff.ly/NTywlR7 https://buff.ly/NTywlR7" [X Link](https://x.com/Xtalks/status/1995500784067244089) 2025-12-01T14:30Z 26.1K followers, [--] engagements "Meet Xtalks Featured Community Member Ankur Dnyanmote PhD Medical Writer at Thermo Fisher Scientific. With two decades of research experience he is pioneering the integration of generative AI in medical writing to enhance the creation of clinical and regulatory documents. Read his story at #LifeSciences #MedicalWriting #AIinScience #Regulatory #ClinicalResearch https://buff.ly/7AeGtMQ https://twitter.com/i/web/status/1995817991338877267 https://buff.ly/7AeGtMQ https://twitter.com/i/web/status/1995817991338877267" [X Link](https://x.com/Xtalks/status/1995817991338877267) 2025-12-02T11:31Z 26K followers, [--] engagements "Pfizer's acquisition of obesity biotech Metsera after a fierce battle with Novo Nordisk dominated the M&A headlines in pharma last month. Other notable M&As in November included Merck's buyout of Cidara for a flu asset and J&J's bet on oncology assets from Halda. Read more at by @AyeshaR1202. https://buff.ly/alUD2Lv https://buff.ly/alUD2Lv" [X Link](https://x.com/Xtalks/status/1996228391020752958) 2025-12-03T14:41Z 26.1K followers, [---] engagements "FDA approves Voyxact for IgA nephropathy (IgAN) the first biologic and first-in-class APRIL-targeting therapy approved for the rare kidney disease. Read more at about a class and space that may see increasing competition soon. #FDA #DrugApproval #Biotech #Pharma #IgAN #RareDisease #Nephrology #KidneyHealth #ClinicalResearch https://buff.ly/kMskSYw https://buff.ly/kMskSYw https://buff.ly/kMskSYw https://buff.ly/kMskSYw" [X Link](https://x.com/Xtalks/status/1996229109798654119) 2025-12-03T14:44Z 26.1K followers, [---] engagements "Notable workforce reductions in pharma & biotech continue as the year winds down. From Novartis cutting over [---] jobs to Catalent bringing its workforce down by several hundred and AbbVie ending its high profile partnership with Alphabet-owned Calico learn about the latest layoffs in pharma & biotech. Read more at by @AyeshaR1202. https://buff.ly/jwJYw9C https://buff.ly/jwJYw9C" [X Link](https://x.com/Xtalks/status/1996659539182039383) 2025-12-04T19:15Z 26.1K followers, [---] engagements "Strengthen your mRNA therapeutics program from the sequence level up with experts Jessica Madigan Manika Bhondeley PhD and Molly McGlaughlin in this webinar hosted by BIOVECTRA. They will examine how rational sequence engineering including codon optimization and UTR selection shapes expression manufacturability and reduces development risk from design to GMP production. Register now to gain actionable insights on aligning sequence attributes with real-world process capabilities IVT yield and regulatory readiness for smoother development and tech transfer: #mRNATherapeutics #GMPManufacturing" [X Link](https://x.com/Xtalks/status/1996897623127511342) 2025-12-05T11:01Z 26.1K followers, [--] engagements "Explore the practical implications of the new ICH GCP E6 (R3) Guideline with Jo Hulbert and Jo Sprague in this webinar hosted by ICON. They will explain the major structural and content changes outlining how the shift to a risk-based approach impacts sponsors investigators and service providers globally. Register now to gain practical steps for comparing R2 and R3 updating procedures and executing successful implementation across all functions: #ICHGCP #ClinicalTrials #RegulatoryCompliance https://buff.ly/cCA3PId https://buff.ly/cCA3PId" [X Link](https://x.com/Xtalks/status/1996911973234061366) 2025-12-05T11:58Z 26.1K followers, [--] engagements "As demand for biologic medications grows global shortages loom over developers seeking to provide a reliable supply to patients in need. Learn about innovative strategies to build more resilient supply chains mitigate risk and prevent potential shortages by FUJIFILM Biotechnologies. Read more at #Biologics #Biopharma #Biomanufacturing https://buff.ly/e5NXCDf https://buff.ly/e5NXCDf" [X Link](https://x.com/Xtalks/status/1998036353880130024) 2025-12-08T14:26Z 26.1K followers, [--] engagements "Learn how to advance your cancer research by accurately modeling the tumor microenvironment (TME) with Shawn Fahl and Meredith Osborn in this webinar hosted by Discovery Life Sciences. They will introduce a novel co-culture approach that integrates tumoroids with CAFs and immune cells overcoming the limitations of traditional models to achieve a true "patient in a dish" complexity. Register now to gain insights into this innovative method and accelerate next-generation oncology drug discovery and personalized medicine: #CancerResearch #TumorMicroenvironment #DrugDiscovery" [X Link](https://x.com/Xtalks/status/1998711070521790899) 2025-12-10T11:07Z 26.1K followers, [--] engagements "Medtronics Robert Kowal MD PhD from the Medtronic Cardiac and Vascular division discusses how their global HFpEF trial is advancing personalized pacing and integrating patient input equity and implementation science into its design. Read more at by @VeraKovacevic3. https://buff.ly/f2j1aoU https://buff.ly/f2j1aoU https://buff.ly/f2j1aoU https://buff.ly/f2j1aoU" [X Link](https://x.com/Xtalks/status/1999435323273576737) 2025-12-12T11:05Z 26K followers, [--] engagements "Dennis Grasela of @BMSNEWS shares how large-scale real-world evidence (RWE) programs are capturing insights from diverse patient populations and healthcare systems to strengthen evidence generation in obstructive hypertrophic cardiomyopathy (oHCM). Read more at by @VeraKovacevic3. https://buff.ly/wETKmCr https://buff.ly/wETKmCr" [X Link](https://x.com/Xtalks/status/2000523490420547626) 2025-12-15T11:09Z 26.1K followers, [--] engagements "The FDA is expanding how RWE can support medical device submissions. It will now accept deidentified patient data such as that from massive patient registries and EHRs as part of RWD in certain medical device submissions. Read more: #FDA #MedicalDevices #FDARegulaton #RWE #RealWorldEvidence #RealWorldData #EHRData #PatientRegistries https://buff.ly/ksIZoaz https://buff.ly/ksIZoaz https://buff.ly/ksIZoaz https://buff.ly/ksIZoaz" [X Link](https://x.com/Xtalks/status/2001970885394149830) 2025-12-19T11:00Z 26.1K followers, [--] engagements "2026 is shaping up to be a defining year for HEOR and market access. From RWEs growing role to AI-supported analyses and outcomes-based payment models heres how evidence and access strategies are evolving at by Soumya Shashikumar. #HEOR #MarketAccess #RealWorldEvidence #HealthEconomics #HealthcareTrends https://buff.ly/MNPWKJk https://buff.ly/MNPWKJk https://buff.ly/MNPWKJk https://buff.ly/MNPWKJk" [X Link](https://x.com/Xtalks/status/2004515079870443902) 2025-12-26T11:30Z 26.1K followers, [--] engagements "From rising cybersecurity and AI expectations to QMSRs [----] start medtech teams will have a clearer view of what regulators want next year. Explore key insights in our medical device regulations [----] blog at by @soumya2390. #MedicalDeviceRegulations #Medtech2026 #FDAUpdates #DigitalHealth #QualitySystems https://buff.ly/LNHmr0d https://buff.ly/LNHmr0d https://buff.ly/LNHmr0d https://buff.ly/LNHmr0d" [X Link](https://x.com/Xtalks/status/2005964629982281816) 2025-12-30T11:30Z 26.1K followers, [--] engagements "As Cervical Health Awareness Month [----] approaches new screening guidance global vaccination efforts and late-stage clinical trials point to where prevention and treatment are headed next. Learn more by @soumya2390 #CervicalHealthAwarenessMonth2026 #CervicalCancer #OncologyResearch #CancerPrevention https://buff.ly/bfhCsUT https://buff.ly/bfhCsUT https://buff.ly/bfhCsUT https://buff.ly/bfhCsUT" [X Link](https://x.com/Xtalks/status/2007044364652916744) 2026-01-02T11:00Z 26.1K followers, [--] engagements "Explore phase-appropriate strategies for bioassay method transfer with Jessica Weaver MRes Katie Harcher MS Julia Hecker PhD and Leigh Laundon PhD in our upcoming webinar hosted by BioAgilytix. Our experts will discuss how to mitigate variability caused by laboratory conditions and reagents while ensuring consistency across global sites through robust documentation and risk-based validation. Register now to learn how to align your processes with FDA and EMA guidance: #BioAgilytix #Bioassay #MethodTransfer #CMC #AssayValidation #RegulatoryCompliance #LifeSciences #DrugDevelopment" [X Link](https://x.com/Xtalks/status/2008639197331026298) 2026-01-06T20:37Z 26.1K followers, [--] engagements "The FDA has approved Cablivi for pediatric patients with the rare blood disorder acquired thrombotic thrombocytopenic purpura (aTTP) alongside plasma exchange and immunosuppressive therapy. Learn how the nanobody therapy works at by @soumya2390. #Sanofi #FDAApproval #aTTP #NanobodyTherapy #PediatricRareDisease https://buff.ly/VsyPNUZ https://buff.ly/VsyPNUZ https://buff.ly/VsyPNUZ https://buff.ly/VsyPNUZ" [X Link](https://x.com/Xtalks/status/2010744424200863766) 2026-01-12T16:03Z 26K followers, [---] engagements "The FDA has shared how it is applying flexibility to CMC requirements for cell and gene therapies spanning clinical development release specifications and process validation as programs move toward BLA review. Dive into our news brief by @soumya2390 at #FDA #CellAndGeneTherapy #CGTManufacturing #BiologicsRegulation #CMC https://buff.ly/bkMUdRa https://buff.ly/bkMUdRa https://buff.ly/bkMUdRa https://buff.ly/bkMUdRa" [X Link](https://x.com/Xtalks/status/2011067722721849462) 2026-01-13T13:28Z 26K followers, [--] engagements "Join us to explore how clinical in-use studies de-risk biotherapeutic development with Daniel Pettit and Natalia Harasimiuk in this insightful webinar hosted by FUJIFILM Biotechnologies. They will examine how stressors during preparation and administration impact therapy and share strategies to mitigate risks such as aggregation adsorption and functional loss through clinical mimic studies. Register now to learn how to design robust fit-for-purpose protocols that align with global regulatory expectations: #FUJIFILM #Biotherapeutics #ClinicalTrials #DrugProductDevelopment #InUseStudies" [X Link](https://x.com/Xtalks/status/2011074442609229903) 2026-01-13T13:54Z 26K followers, [--] engagements "GSK reported Phase III results for bepirovirsen in chronic hepatitis B showing higher functional cure rates vs. standard therapy. Dive into the clinical trial data trial design endpoints and more at by @soumya2390. #GSK #PhaseIII #HepatitisB #Bepirovirsen https://buff.ly/yLTuKaF https://buff.ly/yLTuKaF https://buff.ly/yLTuKaF https://buff.ly/yLTuKaF" [X Link](https://x.com/Xtalks/status/2011098465401516355) 2026-01-13T15:30Z 26K followers, [---] engagements "Eli Lillys oral GLP-1 orforglipron helped patients maintain weight loss after switching off injectable GLP-1s in a first-of-its-kind Phase III trial pointing to a potential pill-based option for long-term obesity management. Read more at #GLP1 #ClinicalTrials #WeightLossDrugs https://buff.ly/MOSGPlN https://buff.ly/MOSGPlN https://buff.ly/MOSGPlN https://buff.ly/MOSGPlN" [X Link](https://x.com/Xtalks/status/2011449096511308235) 2026-01-14T14:43Z 26K followers, [--] engagements "How personalized should patient engagement be in clinical trials @IQVIA_global's Stephanie Galarza shares how thoughtful standardized support can improve retention without compromising scientific integrity. Watch the Xtalks Spotlight and read the full article at by @VeraKovacevic3. #ClinicalTrials #PatientEngagement #PatientCentricity #ClinicalResearch #XtalksSpotlight #IQVIA https://buff.ly/NVLG2qE https://buff.ly/NVLG2qE" [X Link](https://x.com/Xtalks/status/2013622224079466500) 2026-01-20T14:38Z 26K followers, [---] engagements "Gain insights from Dr. Ian Brown from FUJIFILM Biotechnologies about key considerations for process characterization studies including feed material strategy small-scale model verification and data interpretation to support robust CMC submissions. Read more at #Bioprocessing #ProcessCharacterization #CMC #BiopharmaManufacturing https://buff.ly/DfIR6Pr https://buff.ly/DfIR6Pr" [X Link](https://x.com/Xtalks/status/2013722099706175680) 2026-01-20T21:15Z 26K followers, [--] engagements "The FDA has approved AstraZeneca-Daiichi Sankyos ADC Enhertu in combination with Roches Perjeta as a first-line treatment for unresectable or metastatic HER2-positive breast cancer marking the first new frontline option for this subset in more than a decade. Read more at https://buff.ly/rcHeINj https://buff.ly/rcHeINj" [X Link](https://x.com/Xtalks/status/2014343365098094792) 2026-01-22T14:24Z 26K followers, [--] engagements "Learn how to mitigate the risk of protocol deviations in patient enrollment with Catherine Tyner and Craig McLendon in our upcoming webinar hosted by AG Mednet. They will discuss applying a Quality by Design framework to eligibility review as emphasized in the latest FDA draft guidance to prevent costly delays and safeguard data integrity. Register now to explore how centralized workflows and structured eligibility decisions enable more consistent enrollment and reduce downstream operational risk for sponsors and CROs: #AGMednet #ClinicalTrials #PatientEnrollment #FDACompliance" [X Link](https://x.com/Xtalks/status/2014347379097424147) 2026-01-22T14:40Z 26K followers, [--] engagements "Join us to explore how integrated analytical tools advance RNA therapeutics with Todd Giardiello and Diana Cox PhD in this webinar hosted by Rockland Immunochemicals Inc. They will examine how sensitive antibody detection panels enable universal localization and quantification of oligonucleotides while next-generation sequencing maps direct RNA-target interactions across the transcriptome. Register now to learn how combining these complementary technologies can de-risk candidate selection and provide a comprehensive view of therapeutic performance and specificity: #RocklandImmunochemicals" [X Link](https://x.com/Xtalks/status/2014348425030926638) 2026-01-22T14:44Z 26K followers, [--] engagements "Which programs and platforms are drawing investor support in early [----] Our Biotech Funding Tracker highlights recent rounds across neurology immunology oncology and AI-driven drug discovery. Dive in at by @soumya2390. #BiotechFunding #LifeSciences #VentureCapital #DrugDevelopment #BiotechTrends https://buff.ly/fih4K7Z https://buff.ly/fih4K7Z https://buff.ly/fih4K7Z https://buff.ly/fih4K7Z" [X Link](https://x.com/Xtalks/status/2014420809301856386) 2026-01-22T19:32Z 26K followers, [--] engagements "Discover how to optimize cell-based vaccine production with Sara Bursomanno PhD and Chantale Julien in this insightful webinar hosted by Novo Nordisk Pharmatech. They will explore how animal-free recombinant insulin and trypsin improve viral yield and manufacturing efficiency while reducing contamination risks in common systems like Vero and HEK293 cells. Register now to learn how these high-purity reagents deliver enhanced safety and cost-effective production across diverse vaccine platforms: #NovoNordiskPharmatech #VaccineManufacturing #Bioprocessing #CellCulture #RecombinantInsulin" [X Link](https://x.com/Xtalks/status/2014665946237931825) 2026-01-23T11:46Z 26K followers, [--] engagements "Microbial-based biologics pose unique manufacturing challenges. Steve Loftus of FUJIFILM Biotechnologies explains why tailored iterative process development is critical to accelerating IND and early clinical timelines. Read more at #FUGIFILMBiotechnologies #Biologics #ProcessDevelopment #Biomanufacturing https://buff.ly/mH42vVi https://buff.ly/mH42vVi https://buff.ly/mH42vVi https://buff.ly/mH42vVi" [X Link](https://x.com/Xtalks/status/2015810412118217151) 2026-01-26T15:33Z 26K followers, [--] engagements "Explore the future of flexible biologics manufacturing with Charles Heise in this webinar hosted by FUJIFILM Biotechnologies. Our expert will examine how a globally harmonized CDMO model supports rapid technology transfer and how continuous processing strategies can be integrated into single-use facilities. Register now to learn how modular multi-product ecosystems and perfusion-ready cell lines improve supply chain resilience and help drug developers respond to shifting patient needs with agility: #FUJIFILM #Biomanufacturing #CDMO #Biologics #SupplyChain #ContinuousProcessing #TechTransfer" [X Link](https://x.com/Xtalks/status/2015814719714550126) 2026-01-26T15:50Z 26K followers, [--] engagements "Designing more effective meaningful trials for IPF and other rare respiratory diseases requires new thinking. Thermo Fisher Scientifics Francis Jones PhD shares the strategies redefining study design including biomarker-driven selection better patient engagement and technology-enabled data capture. Watch the video and read more at by @VeraKovacevic3. #ClinicalTrials #ClinicalResearch #RareDisease #RespiratoryDisease #IPF https://buff.ly/34xaS8B https://twitter.com/i/web/status/1999227666579308725 https://buff.ly/34xaS8B https://twitter.com/i/web/status/1999227666579308725" [X Link](https://x.com/Xtalks/status/1999227666579308725) 2025-12-11T21:19Z 26K followers, [--] engagements "With its Nasdaq debut Aktis Oncology is funding Phase Ib programs in urothelial and other solid tumors using targeted alpha radiopharmaceuticals. Read about its miniprotein platform and manufacturing plans at by @soumya2390. #Radiopharmaceuticals #AktisOncology #BiotechIPO https://buff.ly/xP7evHv https://buff.ly/xP7evHv https://buff.ly/xP7evHv https://buff.ly/xP7evHv" [X Link](https://x.com/Xtalks/status/2016626747442073856) 2026-01-28T21:37Z 26K followers, [--] engagements "Zepbounds latest TV commercial brings $299 self-pay into focus. Our article breaks down the ads message access options and recent clinical updates across Lillys obesity portfolio at by @soumya2390. #Zepbound #ObesityTreatment #GLP1 #PharmaAdvertising #WeightManagement https://buff.ly/4v8MsMt https://buff.ly/4v8MsMt https://buff.ly/4v8MsMt https://buff.ly/4v8MsMt" [X Link](https://x.com/Xtalks/status/2016627118734483607) 2026-01-28T21:39Z 26K followers, [--] engagements "The Gates Foundation and OpenAI have launched a $50M initiative to support the use of AI in primary care across Africa starting in Rwanda. We examine what Horizon1000 aims to do and how AI could support clinicians facing workforce shortages at by @soumya2390. #GatesFoundation #OpenAI #AfricaHealthcare #ArtificialIntelligence #PrimaryCare https://buff.ly/Ow2wvzk https://buff.ly/Ow2wvzk https://buff.ly/Ow2wvzk https://buff.ly/Ow2wvzk" [X Link](https://x.com/Xtalks/status/2016839245546066317) 2026-01-29T11:42Z 26K followers, [--] engagements "New Phase II data from Roche show sustained weight loss with CT-388 a dual-hormone therapy being studied for obesity. Read the full story at by @soumya2390. #Roche #CT388 #ObesityResearch #GLP1 #GIP https://buff.ly/PPMiMon https://buff.ly/PPMiMon" [X Link](https://x.com/Xtalks/status/2016854346802020800) 2026-01-29T12:42Z 26K followers, [--] engagements "Explore the transformative potential of in vivo CAR T-cell therapies with Juliana Campo Garcia in this technical webinar hosted by GenScript. She will examine how mRNA and lipid nanoparticle (LNP) technologies enable transient controlled CAR expression and targeted delivery directly to immune cells. Register now to gain insights into optimizing platform selection LNP formulation and analytical testing to overcome the common challenges of developing next-generation in vivo immunotherapies: #GenScript #CARTcellTherapy #mRNA #LNPs #InVivo #GeneTherapy #Immunotherapy #Biotech #DrugDelivery" [X Link](https://x.com/Xtalks/status/2016881320740143458) 2026-01-29T14:29Z 26K followers, [--] engagements "Learn how to deliver more with less through centralized FSP models with Suchela Srivatsa and Claire Rielly in this webinar by IQVIA. They will provide a practical stepwise playbook for modernizing clinical operations focusing on how to "right-shore" high-volume tasks like eTMF intake and site visit report reviews to standardize quality and reduce costs. Register now to explore how the framework improves inspection readiness and global oversight while maintaining full control over your data: #IQVIA #ClinicalOperations #FSP #ClinicalTrials #PharmaEfficiency #RightShoring #InspectionReadiness" [X Link](https://x.com/Xtalks/status/2017246499634049323) 2026-01-30T14:40Z 26K followers, [--] engagements "📰 Sagimet Biosciences' oral FASN inhibitor denifanstat is advancing to Phase III trials for MASH. The study set to start by year-end aims to enroll [----] patients. Read more at by @AyeshaR1202. https://buff.ly/3Avsb59 https://buff.ly/3Avsb59" [X Link](https://x.com/Xtalks/status/1854162725603000770) 2024-11-06T14:03Z 26K followers, [---] engagements "📰 Journey Medical has received FDA approval for its rosacea drug Emrosi. Read more at by @AyeshaR1202 about the drug and how Journey is hoping it could rival the current standard-of-care treatment for rosacea. #Rosacea #Dermatology https://buff.ly/3AwcwCJ https://buff.ly/3AwcwCJ" [X Link](https://x.com/Xtalks/status/1854652586512482722) 2024-11-07T22:30Z 26K followers, [---] engagements "Roche's $1.5B acquisition of Poseida Therapeutics is set to advance off-the-shelf CAR-T treatments. With scalable solutions patients battling cancers and autoimmune diseases could soon see faster accessible therapies. Learn more at by @soumya2390. https://buff.ly/3OwbU3i https://buff.ly/3OwbU3i" [X Link](https://x.com/Xtalks/status/1862540840410792178) 2024-11-29T16:55Z 26K followers, [---] engagements "In this episode hear about Intensity Therapeutics innovative intratumoral therapeutics currently in trials for soft tissue sarcoma and breast cancer from company founder chairman and CEO Lewis Bender. Listen now at 🎙 https://buff.ly/3Zxe7kd https://buff.ly/3Zxe7kd" [X Link](https://x.com/Xtalks/status/1867596817136767397) 2024-12-13T15:45Z 26K followers, [---] engagements "Neurocrine Biosciences Crenessity (crinecerfont) has been approved as the first new treatment in decades for the rare genetic disorder congenital adrenal hyperplasia (CAH). Read more at by @AyeshaR1202 about the approval. https://buff.ly/401RSnK https://buff.ly/401RSnK" [X Link](https://x.com/Xtalks/status/1869495355231870996) 2024-12-18T21:30Z 26K followers, [---] engagements "Aardvark Therapeutics IPO launches with $94.2M in capital fueling breakthrough research in hyperphagia and Prader-Willi syndrome. Learn more about Aardvarks next-gen pipeline for metabolic diseases at by @soumya2390. https://buff.ly/3XcgGb2 https://buff.ly/3XcgGb2" [X Link](https://x.com/Xtalks/status/1894007146494259526) 2025-02-24T12:51Z 26K followers, [---] engagements "✨ The 200th episode of the Xtalks Life Science Podcast is here Hear from Coya Therapeutics CEO Dr. Arun Swaminathan as he discusses the companys innovative immunotherapeutic approach to enhancing Treg function in diseases like ALS and Alzheimers at https://buff.ly/q2VMFwu https://buff.ly/q2VMFwu" [X Link](https://x.com/Xtalks/status/1902356793080377648) 2025-03-19T13:49Z 26K followers, [---] engagements "In this episode Unicycive Therapeutics founder and CEO Dr. Shalabh Gupta discusses the current unmet needs in kidney diseases and Unicycives innovative approaches to addressing them. Listen now at 🎙 https://buff.ly/J2LvFyw https://buff.ly/J2LvFyw" [X Link](https://x.com/Xtalks/status/1904992513775087730) 2025-03-26T20:23Z 26K followers, [---] engagements "Soleno Therapeutics Vykat XR received FDA approval for hyperphagia in patients with Prader-Willi syndrome (PWS). Read more at by @AyeshaR1202 about the treatment. https://buff.ly/1YK8NjX https://buff.ly/1YK8NjX" [X Link](https://x.com/Xtalks/status/1912619488844866026) 2025-04-16T21:29Z 26K followers, [---] engagements "Precision psychiatry is reshaping neuropsychiatric clinical trials. Alto Neurosciences Dr. Amit Etkin discusses how harnessing biomarkers EEG and wearables to tailor therapies can cut placebo noise and boost success. Read more in our Xtalks Clinical Edge feature at by @AyeshaR1202. https://buff.ly/CZRiP8C https://buff.ly/CZRiP8C" [X Link](https://x.com/Xtalks/status/1922625735023272426) 2025-05-14T12:11Z 26K followers, [---] engagements "Shoulder Innovations just raised $75M in its NYSE IPO to expand its AI-powered planning implant lineup & outpatient-friendly tools for shoulder surgery. Learn how this medtech debut supports arthroplasty innovation at by @soumya2390. #ShoulderInnovationsIPO #ShoulderSurgery #MedicalDevices #Orthopedics #Arthroplasty #IPO2025 #SurgicalInnovation #HealthcareInvesting #ReverseShoulder #AnatomicShoulder https://buff.ly/NsxUMa7 https://buff.ly/NsxUMa7 https://buff.ly/NsxUMa7 https://buff.ly/NsxUMa7" [X Link](https://x.com/Xtalks/status/1955282456426275277) 2025-08-12T14:57Z 26K followers, [---] engagements "🧬 How can you decode the tumor microenvironment to accelerate therapeutic discovery Join QIAGEN for a webinar with Kristin OMalley to explore how curated biological knowledge and predictive modeling tools can help translational scientists make sense of complex omics data. Learn how to construct molecular networks interpret gene expression datasets and predict immune and tumor behavior including insights from Interleukin1 beta in NSCLC. Register now: #TumorMicroenvironment #PredictiveModeling #TranslationalScience #QIAGEN #OncologyResearch https://buff.ly/C0Ookw4 https://buff.ly/C0Ookw4" [X Link](https://x.com/Xtalks/status/1970070871655022874) 2025-09-22T10:21Z 26K followers, [---] engagements "With $285M from its IPO LB Pharmaceuticals will fund new trials of its investigational drug LB-102 for schizophrenia and bipolar depression. Explore how this biopharma is advancing neuropsychiatry care at by @soumya2390. #LBPharmaceuticals #LBRX #LBPharmaIPO #Biotech #Neuropsychiatry #SchizophreniaResearch #BipolarDepression #ClinicalTrials #InvestigationalDrug https://buff.ly/hNn53j1 https://buff.ly/hNn53j1 https://buff.ly/hNn53j1 https://buff.ly/hNn53j1" [X Link](https://x.com/Xtalks/status/1981728927585345795) 2025-10-24T14:26Z 26K followers, [--] engagements "Novartis is making a $12B move into RNA therapeutics with the acquisition of Avidity Biosciences. The deal adds Aviditys RNA platform and late-stage programs for Duchenne DM1 and FSHD bolstering Novartiss neuromuscular disease pipeline. Read more at #RNAtherapeutics #DuchenneMuscularDystrophy #MergersAndAcquisitions #Novartis #AvidityBiosciences https://buff.ly/s99ur59 https://twitter.com/i/web/status/1985416691166175627 https://buff.ly/s99ur59 https://buff.ly/s99ur59 https://twitter.com/i/web/status/1985416691166175627 https://buff.ly/s99ur59" [X Link](https://x.com/Xtalks/status/1985416691166175627) 2025-11-03T18:40Z 26K followers, [---] engagements "Thermo Fisher Scientifics Francis Jones PhD shares how precision medicine meaningful endpoints and evolving technologies are influencing study design for IPF and other rare respiratory diseases. Watch the video and read more at by @VeraKovacevic3. #ClinicalTrials #ClinicalResearch #RareDisease #RespiratoryDisease #IPF https://buff.ly/34xaS8B https://twitter.com/i/web/status/2001628590350237821 https://buff.ly/34xaS8B https://buff.ly/34xaS8B https://twitter.com/i/web/status/2001628590350237821 https://buff.ly/34xaS8B" [X Link](https://x.com/Xtalks/status/2001628590350237821) 2025-12-18T12:20Z 26K followers, [--] engagements "Learn how to accelerate drug development through master protocol trial designs with Melanie Owen MS Susie Cain RAC and Song Wang in this webinar hosted by Thermo Fisher Scientific. They will explore how evaluating multiple investigational products under a single infrastructure streamlines coordination and provides the adaptive design flexibility needed to modify studies based on treatment performance. Register now to gain insights into implementing these complex clinical trials to improve decision-making and eliminate the need for redundant trial protocols: #ThermoFisherScientific #PPD" [X Link](https://x.com/Xtalks/status/2009300008537833984) 2026-01-08T16:23Z 26K followers, [---] engagements "Sarepta released new 3-year trial data examining long-term outcomes and safety for Elevidys in Duchenne muscular dystrophy (DMD) a rare childhood muscle disease. Read more about the clinical trial at by @soumya2390. #Elevidys #DuchenneMuscularDystrophy #GeneTherapy #RareDisease https://buff.ly/hOyeD9k https://buff.ly/hOyeD9k https://buff.ly/hOyeD9k https://buff.ly/hOyeD9k" [X Link](https://x.com/Xtalks/status/2017315564197183721) 2026-01-30T19:14Z 26K followers, [---] engagements "Evaluate how early protocol design decisions impact clinical supply strategy and RTSM performance with Jennifer Cobb Foulkes Jennifer Teti Savannah Holt and Jonathan Pritchard in this collaborative webinar hosted by 4G Clinical. They will examine how specific design choices from kit architecture and expiry strategy to pooling models and resupply logic directly shape trial execution and influence forecasting accuracy. Register now to learn how to bridge the gap between protocol intent and operational readiness while exploring how emerging AI technologies are transforming the future of supply" [X Link](https://x.com/Xtalks/status/2018329840223441095) 2026-02-02T14:25Z 26K followers, [--] engagements "Each biologic has its own unique formulation challenges. Madison White Senior Scientist at FUJIFILM Biotechnologies discusses how a structured data-rich formulation approach can help de-risk development and support preclinical readiness. Read more at #Biologics #Formulation #Biotech #FUJIFILMBiotechnologies https://buff.ly/TpDjs4Y https://buff.ly/TpDjs4Y https://buff.ly/TpDjs4Y https://buff.ly/TpDjs4Y" [X Link](https://x.com/Xtalks/status/2018330077637820467) 2026-02-02T14:26Z 26K followers, [--] engagements "In this episode hear Domp Chief Development Officer Dr. Ahmed Enayetallah discuss innovative therapeutic approaches based on nerve growth factor (NGF) biology in ocular diseases with high unmet need such as NAION. Listen now at 🎙 https://buff.ly/QIjM0Nr https://buff.ly/QIjM0Nr" [X Link](https://x.com/Xtalks/status/2019149182125133935) 2026-02-04T20:40Z 26K followers, [--] engagements "Explore how community-based trial models prioritize the patient experience with Deon Miller DO Nancy Lizzul and Lou Cappoli in this webinar hosted by EmVenio Clinical Research. They will share real-world data on how localized engagement strategies including community-site networks and mobile research units overcome traditional barriers to improve enrollment and retention. Register now to learn how these models strengthen patient trust and provide the key metrics needed to advance health equity and inclusivity across diverse therapeutic areas: #EmVenio #ClinicalResearch #CommunityBasedResearch" [X Link](https://x.com/Xtalks/status/2019370194011898279) 2026-02-05T11:19Z 26K followers, [--] engagements "The FDA has issued a complete response letter for AstraZenecas subcutaneous anifrolumab in systemic lupus erythematosus (SLE). Heres what the decision means and what comes next at by @soumya2390. #FDA #SystemicLupusErythematosus #LupusResearch #Biologics #DrugRegulation https://buff.ly/xboxnic https://buff.ly/xboxnic https://buff.ly/xboxnic https://buff.ly/xboxnic" [X Link](https://x.com/Xtalks/status/2019458034666217769) 2026-02-05T17:08Z 26K followers, [--] engagements "Navigate the complexities of site selection in rare disease research with Paula Orandash and Benjamen Varsano in this strategic webinar hosted by Ergomed. They will demonstrate how a "three-pillar" landscape analysis uncovers critical insights that traditional historical data often misses. Register now to learn how early investment in patient-centric intelligence and real-world treatment patterns can shorten timelines improve recruitment feasibility and ensure more ethical study designs: #Ergomed #RareDisease #ClinicalTrials #LandscapeAnalysis #PatientEngagement #SiteSelection" [X Link](https://x.com/Xtalks/status/2019733838188904737) 2026-02-06T11:24Z 26K followers, [--] engagements "The US Food and Drug Administration (FDA) has approved Luye Pharmas Rykindo for the treatment of #schizophrenia and as a monotherapy or adjunctive #therapy for the maintenance treatment of #bipolardisorder in adults. Read more on this story here: https://buff.ly/3HDuG64 https://buff.ly/3HDuG64" [X Link](https://x.com/Xtalks/status/1619742333720748039) 2023-01-29T17:00Z 26K followers, [---] engagements "In this episode Xtalks interviews two experts from CytoMed Therapeutics Mr. Choo Chee Kong & Dr. Tan Wee Kiat about the companys mission to develop more affordable #cellular #cancer therapies the launch of the companys new IPO & more. Listen here: https://buff.ly/3PNLZWJ https://buff.ly/3PNLZWJ" [X Link](https://x.com/Xtalks/status/1678064024045355008) 2023-07-09T15:30Z 26K followers, [---] engagements "We spoke with Dr. Taylor H. Schreiber CEO and Co-Founder of Shattuck Labs about the companys pioneering approach to developing dual-function fusion proteins for the treatment of #cancer and #autoimmunediseases. Read more by @VeraKovacevic3: #Biologics https://buff.ly/3Pv7E5h https://buff.ly/3Pv7E5h" [X Link](https://x.com/Xtalks/status/1765030557769969918) 2024-03-05T15:04Z 26K followers, [---] engagements "The complexity of biological systems poses challenges in drug discovery. Join our virtual event by Akoya Biosciences to learn how advancements in spatial biology can optimize therapeutic development: #SpatialBiology #DrugDiscovery #Webinar https://buff.ly/4enxBxe https://buff.ly/4enxBxe" [X Link](https://x.com/Xtalks/status/1855996430164296175) 2024-11-11T15:30Z 26K followers, [---] engagements "Jupiter Neurosciences launches its $11M IPO on Nasdaq aiming to advance its investigational drug Jotrol a resveratrol-based innovation targeting CNS disorders like Parkinsons and Alzheimers. Explore their platform and partnerships at by @soumya2390. https://buff.ly/3ZgDnem https://buff.ly/3ZgDnem" [X Link](https://x.com/Xtalks/status/1864673870113865733) 2024-12-05T14:11Z 26K followers, [---] engagements "Maze Therapeutics has arrived with its IPO offering bringing with it genetically targeted treatments aimed at APOL1-mediated kidney disease. Learn more at by @soumya2390. https://buff.ly/3CBtdO9 https://buff.ly/3CBtdO9" [X Link](https://x.com/Xtalks/status/1886886513868193884) 2025-02-04T21:16Z 26K followers, [---] engagements "Beta Bionics has successfully raised $234.6 million from its IPO which will fund the commercialization and clinical trials of its flagship product the iLet bionic pancreas system. Learn more about the insulin dosing management system at by @soumya2390. https://buff.ly/3Qd3uPb https://buff.ly/3Qd3uPb" [X Link](https://x.com/Xtalks/status/1889321136560738685) 2025-02-11T14:30Z 26K followers, [---] engagements "Sionna Therapeutics IPO has arrived in the cystic fibrosis landscape. Leveraging innovative NBD1 stabilizers its lead candidates SION-719 and SION-451 are currently in Phase I trials targeting the critical F508del mutation. More at by @soumya2390. https://buff.ly/4ia0IGw https://buff.ly/4ia0IGw" [X Link](https://x.com/Xtalks/status/1892990167142576287) 2025-02-21T17:30Z 26K followers, [---] engagements "Kestra Medical Technologies IPO raises $202M bolstering its wearable cardioverter defibrillator and digital health platform. Learn more about Kestra at by @soumya2390. https://buff.ly/4wvzVKX https://buff.ly/4wvzVKX" [X Link](https://x.com/Xtalks/status/1901630777970106584) 2025-03-17T13:44Z 26K followers, [---] engagements "In this episode Vera Therapeutics founder and CEO Dr. Marshall Fordyce discusses the current landscape of autoimmune diseases and how his company is innovating treatments for IgA nephropathy. Listen now at 🎙 https://buff.ly/PxDYf0L https://buff.ly/PxDYf0L" [X Link](https://x.com/Xtalks/status/1907880690617606312) 2025-04-03T19:39Z 26K followers, [---] engagements "Hinge Health IPO debuts at $437.3M merging AI wearables and human care to advance musculoskeletal health. Explore how their FDA-cleared Enso device and TrueMotion tech aim to reshape pain care at by @soumya2390. https://buff.ly/gEYhbwQ https://buff.ly/gEYhbwQ" [X Link](https://x.com/Xtalks/status/1928193784124182818) 2025-05-29T20:56Z 26K followers, [---] engagements "❓ How can we avoid hidden pitfalls in bioinformatics workflows Join Bullfrog AIs webinar with Juan Felipe Beltrn to explore common issues in AI-powered computational biology workflows including mismanaging compositional data overinterpreting ML feature importance and misapplying generative AI for ranking tasks. Register now: #Bioinformatics #MachineLearning #AIinBioinformatics #DrugDiscovery #BioinformaticsChallenges #BullfrogAI https://buff.ly/xzyNeGx https://twitter.com/i/web/status/1931020102456975686 https://buff.ly/xzyNeGx https://twitter.com/i/web/status/1931020102456975686" [X Link](https://x.com/Xtalks/status/1931020102456975686) 2025-06-06T16:07Z 26K followers, [---] engagements "The Omada Health IPO is official. The company raised $120M to expand its digital programs for musculoskeletal diabetes and GLP-1 support. We explore whats next for Omada and what the filing reveals at by @soumya2390. https://buff.ly/bD2KZjo https://buff.ly/bD2KZjo" [X Link](https://x.com/Xtalks/status/1936158606526656718) 2025-06-20T20:25Z 26K followers, [---] engagements "Dr. Marshall Fordyce Founder and CEO of @Official_VeraTx shares how a science-first strategy is driving progress in IgA nephropathy (IgAN) and beyond. From designing rigorous trials to embedding patient and physician voices at every step Vera Therapeutics is redefining what it means to develop targeted patient-centered therapies. Read the full story in this Xtalks Clinical Edge interview at by Mohammad Ali. #AutoimmuneDiseases #IgAN #KidneyHealth #CKD #ClinicalResearch #DrugDevelopment #PatientCentricity #LifeSciences #Biotech #Pharma #XtalksClinicalEdge https://buff.ly/ElYX32u" [X Link](https://x.com/Xtalks/status/1960744141282799809) 2025-08-27T16:40Z 26K followers, [---] engagements "❓ How can you turn messy clinical PDFs into analysis-ready datasets without losing human oversight Join BullFrog AIs webinar with Juan Felipe Beltrn Lacouture PhD to learn how bfPREPTM and bfLEAPTM streamline clinical data intake entity resolution and OMOP structuring. Discover practical templates agent-powered workflows and verified automation strategies that preserve human judgment while accelerating analysis-ready outputs. Register now: #ClinicalData #DataAutomation #OMOP #MachineLearning #BullFrogAI #AgenticAI https://buff.ly/xvx6klK https://twitter.com/i/web/status/1971571748760879542" [X Link](https://x.com/Xtalks/status/1971571748760879542) 2025-09-26T13:45Z 26K followers, [---] engagements "MapLight Therapeutics IPO raised around $296M to fund Phase II trials of its muscarinic-based therapy for schizophrenia and Alzheimers psychosis. Learn how this clinical-stage biotech is advancing CNS drug discovery at by @soumya2390. #MapLightTherapeutics #BiotechIPO #CNS #DrugDiscovery #Neuroscience https://buff.ly/vuGdJxZ https://buff.ly/vuGdJxZ https://buff.ly/vuGdJxZ https://buff.ly/vuGdJxZ" [X Link](https://x.com/Xtalks/status/1985432292462899582) 2025-11-03T19:42Z 26K followers, [---] engagements "Bausch + Lombs campaign for dry eye disease treatment Miebo features American sportscaster Erin Andrews with an ad spot showing her battling gritty eyes and at pop ups in New York. Read more at #DryEyeDisease #Bausch+Lomb https://buff.ly/Mwj4Mcv https://buff.ly/Mwj4Mcv" [X Link](https://x.com/Xtalks/status/1986456106353246678) 2025-11-06T15:30Z 26K followers, [---] engagements "Structure Therapeutics reported positive Phase II data for its oral GLP-1 agonist aleniglipron in adults with obesity or overweight. The results support plans for Phase III development. Dive into the clinical trial data at by @soumya2390. #StructureTherapeutics #ClinicalTrials #ObesityResearch #GLP1 #Aleniglipron https://buff.ly/DxWvAuR https://buff.ly/DxWvAuR" [X Link](https://x.com/Xtalks/status/2000603899795812707) 2025-12-15T16:28Z 26K followers, [--] engagements "Eli Lillys next-generation obesity drug #retatrutide outperformed its current blockbuster Zepbound in a late-stage trial delivering greater weight loss and easing knee pain in patients with osteoarthritis. Read more: #EliLilly #ClinicalTrials #ObesityDrugs #WeightLossDrugs #GLP1Drugs #Zepbound https://twitter.com/i/web/status/2001819808992550942 https://buff.ly/xfUq30t https://twitter.com/i/web/status/2001819808992550942 https://buff.ly/xfUq30t" [X Link](https://x.com/Xtalks/status/2001819808992550942) 2025-12-19T01:00Z 26K followers, [---] engagements ".@EliLillyandCo announces its roster of Team USA athletes for Milano Cortina [----] and pledges to turn Olympic and Paralympic milestones into meaningful community impact. Every medal earned will support US nonprofits improving health access: #EliLilly #TeamUSA #MilanoCortina2026 #HealthEquity #CommunityHealth #Olympics #Paralympics #Lilly https://buff.ly/2Fu0w8U https://twitter.com/i/web/status/2008205188457238656 https://buff.ly/2Fu0w8U https://buff.ly/2Fu0w8U https://twitter.com/i/web/status/2008205188457238656 https://buff.ly/2Fu0w8U" [X Link](https://x.com/Xtalks/status/2008205188457238656) 2026-01-05T15:53Z 26K followers, [--] engagements "Cytokinetics has won FDA approval for Myqorzo (aficamten) for the treatment of symptomatic obstructive hypertrophic cardiomyopathy (oHCM) marking the companys first commercial product and its entry into a market led by Bristol Myers Squibbs Camzyos. Read more at #HCM #Cardiomyopathy #Myqorzo #Cytokinetics #FDAApproval https://buff.ly/1QfAGnX https://buff.ly/1QfAGnX" [X Link](https://x.com/Xtalks/status/2015810621766287642) 2026-01-26T15:34Z 26K followers, [----] engagements "Explore how organizations can achieve local compliance on a global scale with Jay Gandecha and Ana Pedro Jesuno in this strategic webinar hosted by IQVIA. They will discuss the benefits of integrating Local Qualified Person for Pharmacovigilance (LQPPV) responsibilities with comprehensive Lifecycle Management (LCM) to create unified governance and reduce operational duplication across the enterprise. Register now to discover how applied AI and adaptive resourcing models can allow sponsors to maintain high compliance standards across complex multi-country environments without being locked into" [X Link](https://x.com/Xtalks/status/2021594415026823540) 2026-02-11T14:37Z 26K followers, [--] engagements "In this episode INmune Bio CEO David Moss discusses targeting innate immunity therapeutically in diseases driven by chronic inflammation from the rare genetic disease RDEB to Alzheimers. Listen now at 🎙 https://buff.ly/Tze1NQm https://buff.ly/Tze1NQm" [X Link](https://x.com/Xtalks/status/2021703129343955256) 2026-02-11T21:49Z 26K followers, [--] engagements "Medtech layoffs in early [----] are affecting both device manufacturers and diagnostics companies with workforce reductions tied to site closures restructuring and contract changes. See whos getting affected at by @soumya2390. #MedtechLayoffs #MedicalDevices #MedtechIndustry #Diagnostics #Manufacturing https://buff.ly/SWcQVVQ https://buff.ly/SWcQVVQ" [X Link](https://x.com/Xtalks/status/2022047313514959325) 2026-02-12T20:37Z 26K followers, [--] engagements "Karuna Therapeutics revealed Phase III EMERGENT-2 trial results for their investigational drug KarXT in #schizophrenia published in The Lancet. Read more about the clinical trial data at #ClinicalResearch #Psychiatry #NeuroscienceClinicalTrials https://buff.ly/3NXilNd https://buff.ly/3NXilNd" [X Link](https://x.com/Xtalks/status/1739609524061806678) 2023-12-26T11:30Z 26K followers, [---] engagements "Caris Life Sciences is building an AI-led diagnostics and oncology drug discovery engine backed by $494M from its [----] IPO. Our article by @soumya2390 at walks through the companys tools partnerships and where it's headed. https://buff.ly/dHgVmrQ https://buff.ly/dHgVmrQ" [X Link](https://x.com/Xtalks/status/1937968471435776041) 2025-06-25T20:17Z 26K followers, [---] engagements "Who employs the most in pharma and healthcare 🌍 From biotech titans and legacy pharma to retail pharmacy giants and global CROs workforce size tells a powerful story of influence scale and global reach. 🔹 CVS Health and Walgreens Boots Alliance top the list not for R&D but for their vast retail and insurance operations. 🔹Johnson & Johnson Pfizer Roche and AstraZeneca remain R&D powerhouses with global commercial infrastructure. 🔹Sinopharm and CR Pharma companies based in China are rapidly scaling. 🔹Europe continues to lead with Sanofi Novo Nordisk Bayer and Novartis maintaining large" [X Link](https://x.com/Xtalks/status/1956441673136759104) 2025-08-15T19:43Z 26K followers, [---] engagements "Ivonescimab delivers survival benefits in EGFR-mutant NSCLC. Final trial data from China show improved PFS and OS with ivonescimab + chemo vs chemo alone. Makers Akeso and Summit Therapeutics plan to submit a BLA in Q4 [----]. Read more at #Ivonescimab #LungCancer #NSCLC #Oncology #Akeso #ClinicalTrials https://buff.ly/hTbgwUr https://buff.ly/hTbgwUr" [X Link](https://x.com/Xtalks/status/1995498700336947329) 2025-12-01T14:22Z 26K followers, [---] engagements "Explore how to accelerate the transition from First-in-Human (FIH) to Proof-of-Concept (POC) with Aatir Butt in this webinar hosted by Fortrea. Our expert will discuss how adaptive study designs can eliminate "white space" between milestones enabling sponsors to respond dynamically to emerging data and streamline decision-making. Register now to learn how strategic site selection can enhance operational delivery and support the complex protocols of Phase I/Ib trials: #Fortrea #ClinicalTrials #EarlyPhase #PhaseI #DrugDevelopment #AdaptiveDesign #FirstInHuman #ProofOfConcept #Biotech" [X Link](https://x.com/Xtalks/status/2022275588036206968) 2026-02-13T11:44Z 26K followers, [--] engagements "In this episode hear from Kairos Pharmas CEO Dr. Yu about the companys focus on developing therapeutics that counter cancer drug resistance. Listen now at 🎙 https://buff.ly/3ZfGinq https://buff.ly/3ZfGinq" [X Link](https://x.com/Xtalks/status/1864786233253052872) 2024-12-05T21:37Z 26K followers, [---] engagements "Zhengye Biotechnologys IPO positions the company for rapid growth in the global veterinary vaccine market. With $6M raised Zhengye plans to expand its vaccine portfolio enhancing animal health worldwide. Learn more at by @soumya2390. https://buff.ly/4j6091A https://buff.ly/4j6091A" [X Link](https://x.com/Xtalks/status/1878879942282256451) 2025-01-13T19:01Z 26K followers, [---] engagements "Ascentage Pharma's IPO brings a new wave of targeted therapies such as olverembatinib and lisaftoclax for hematological cancers. Learn more about the companys innovative approach at by @soumya2390. https://buff.ly/42wPaZp https://buff.ly/42wPaZp" [X Link](https://x.com/Xtalks/status/1884328210025812210) 2025-01-28T19:50Z 26K followers, [---] engagements "Advanced Biomeds IPO raised $6.56M fueling innovative liquid biopsy testing for early cancer detection. Discover how their microfluidic platform could advance cancer diagnostics for better patient outcomes at by @soumya2390. https://buff.ly/hR80rJD https://buff.ly/hR80rJD" [X Link](https://x.com/Xtalks/status/1901721830043595197) 2025-03-17T19:46Z 26K followers, [---] engagements "Cuprina Holdings IPO raises $12M to fund bio-dressings for diabetic foot venous leg and pressure ulcers powered by maggot therapy and collagen from bullfrog-skin waste. Learn more about the IPO at by @soumya2390. https://buff.ly/oevHRsi https://buff.ly/oevHRsi" [X Link](https://x.com/Xtalks/status/1912574784111624373) 2025-04-16T18:32Z 26K followers, [---] engagements "Apimeds Pharmaceuticals US IPO brings a fresh angle to drug development: intradermal bee venom delivery. With plans for a new Phase III trial learn more about this unique approach at by @soumya2390. https://buff.ly/BkYT02e https://buff.ly/BkYT02e" [X Link](https://x.com/Xtalks/status/1925286431477391629) 2025-05-21T20:23Z 26K followers, [---] engagements "Picard Medical IPO raises $19.55M on NYSE American. Parent of SynCardia the company develops the only FDA- and Health Canada-approved total artificial heart. Learn what this means for patients at by @soumya2390. #PicardMedicalIPO #PicardMedical #SynCardia #ArtificialHeart #MedicalDevices #HeartFailure #BiventricularFailure #CardiacCare #MedTech #Cardiology #MedicalTechnology https://buff.ly/3YrNn7D https://buff.ly/3YrNn7D" [X Link](https://x.com/Xtalks/status/1969078818531885254) 2025-09-19T16:39Z 26K followers, [---] engagements "FDA approves Vizz (aceclidine eye drops) for presbyopia a non-surgical option for adults with age-related near vision loss. Learn how LENZ Therapeutics once-daily drop restores focus for up to [--] hours at by @soumya2390. #Vizz #Aceclidine #LENZTherapeutics #FDAApproval #Presbyopia #EyeCare #Ophthalmology #VisionHealth #PharmaNews #DrugDevelopment #EyeDrops #AgeRelatedVisionLoss #HealthcareNews #LifeSciences #EyeTreatment #FDA #PrescriptionDrugs https://buff.ly/PCIMwGo https://buff.ly/PCIMwGo" [X Link](https://x.com/Xtalks/status/1980374075659690251) 2025-10-20T20:42Z 26K followers, [---] engagements "Medtronics MiniMed Go smart multiple daily injection (MDI) system has received the green light from the FDA. Integrated with Abbotts Instinct sensor it offers personalized automated insulin delivery. Read more at #Diabetes #CGM #Medtronic #MiniMed https://buff.ly/F1eFbaX https://buff.ly/F1eFbaX" [X Link](https://x.com/Xtalks/status/2014359967654879652) 2026-01-22T15:30Z 26K followers, [--] engagements "The 7th issue of Xtalks Clinical Edge is here A special thanks to our front-cover interviewee Martin Beck Boehringer Ingelheim for sharing insights on improving awareness and patient-centered research in idiopathic pulmonary fibrosis. See more for [--] in-depth conversations with leaders advancing clinical research across therapeutic areas: 🧬 Immunology & Inflammatory Disease Paul F. Lizzul MD PhD MPH MBA AnaptysBio Niels Riedemann MD PhD InflaRx 👩🔬 Respiratory Research Martin Beck Boehringer Ingelheim Barry Quart PharmD Connect Biopharma 🧠 Neurology Ophthalmology & Ischemic Disease Ahmed" [X Link](https://x.com/Xtalks/status/2021953446480396426) 2026-02-12T14:24Z 26K followers, [---] engagements "Unlock high-value insights in early-phase oncology trials with Todd Rudo MD Anu Bansal MD MS Robert Kleiman MD and Kelly Dumais PhD in this webinar hosted by Clario. They will examine how advanced image analysis and concentration-effect modeling for cardiac safety are delivering deeper more sensitive data than traditional strategies. Register now to learn how integrating early patient-reported endpoints and pharmacokinetics can strengthen clinician assessments and support rapid evidence-based dose selection: #Clario #Oncology #EarlyPhase #ClinicalTrials #MedicalImaging #CardiacSafety #eCOA" [X Link](https://x.com/Xtalks/status/2021956902519734298) 2026-02-12T14:37Z 26K followers, [--] engagements "Healthcare layoffs continue into [----] as hospitals payers and healthcare services organizations adjust staffing amid funding and cost pressures. See the roundup at by @soumya2390. #HealthcareLayoffs #HealthcareWorkforce #Hospitals #HealthInsurance #Medicaid #HealthcareNews https://buff.ly/D9uaXZC https://buff.ly/D9uaXZC" [X Link](https://x.com/Xtalks/status/2022016862016454868) 2026-02-12T18:36Z 26K followers, [--] engagements "Pharma touched down at [----] Super Bowl LX with drugmakers like Novartis Novo Nordisk and Boehringer Ingelheim using the Big Game to spotlight disease screening GLP-1 weight-loss drugs and more. Read more at #SuperBowlLX #PharmaAds #HealthAwareness https://buff.ly/gNZ5Oyj https://buff.ly/gNZ5Oyj" [X Link](https://x.com/Xtalks/status/2022031206737486274) 2026-02-12T19:33Z 26K followers, [--] engagements "AstraZenecas $1.2B agreement with CSPC spans eight obesity and type [--] diabetes programs and includes AI-enabled peptide discovery and once-monthly dosing technology. Heres more on the AstraZeneca-CSPC Pharma deal by @soumya2390 at #AstraZeneca #Obesity #Type2Diabetes #GLP1 #DrugDevelopment #Biopharma https://buff.ly/KDuIAqC https://buff.ly/KDuIAqC" [X Link](https://x.com/Xtalks/status/2022062664910872986) 2026-02-12T21:38Z 26K followers, [--] engagements "From R&D centers to manufacturing sites AstraZenecas $15B China investment details how the company plans to scale development and production through [----]. Heres a closer look at the AstraZeneca China investment at by @soumya2390 . #AstraZeneca #ChinaInvestment #DrugDevelopment #Biopharma #LifeSciences https://buff.ly/AsAhVKv https://buff.ly/AsAhVKv" [X Link](https://x.com/Xtalks/status/2022323920351776793) 2026-02-13T14:56Z 26K followers, [--] engagements "🔁 Friday Rewind with Xtalks Heres a quick catch-up on what crossed our radar this past week. Read about new partnerships investment plans an FDA-cleared at-home cancer treatment device and updated trackers on layoffs and deal activity. 🤝 AstraZeneca Partners with CSPC in a $1.2B Obesity and Metabolic Disease Deal Read the deal details: 💰 AstraZenecas $15B China Plan: More R&D and Manufacturing Through [----] See whats included: 🩺 FDA Clears Optune Pax for At-Home Treatment of Pancreatic Cancer Get the clearance update: 🏥 Healthcare Layoffs 2026: Track Current Job Cuts Browse the latest" [X Link](https://x.com/Xtalks/status/2022402809442763209) 2026-02-13T20:09Z 26K followers, [--] engagements "Thinking About #Healthcare Startups Here Are [--] Things You Need to Know There has never been a better time to be a motivated entrepreneur looking to launch their own healthcare startup. But getting started takes more than a bright idea and seed funding. https://buff.ly/2u6IIql https://buff.ly/2u6IIql" [X Link](https://x.com/Xtalks/status/1139563239728193536) 2019-06-14T16:00Z 27.1K followers, [--] engagements "What were going to see in the future is a lot more decision making and knowledge based upon types of data analytics and data acquisition thats being undertaken says @CluePoints Patrick Hughes on the future of #clinicaltrials at #DIA2019" [X Link](https://x.com/Xtalks/status/1143256067578593280) 2019-06-24T20:34Z 27.1K followers, [--] engagements "Interactive Response Technology manages #clinicaltrial randomization and getting the right investigational product (IP) to the right #patient at the right time. But what happens when trials do not mature as expected Sign up to find out from @bioclinica https://buff.ly/3hvKIBQ https://buff.ly/3hvKIBQ" [X Link](https://x.com/Xtalks/status/1441107623223304199) 2021-09-23T18:30Z 26.7K followers, [--] engagements "Biohaven Pharmaceutical announced positive results from a Phase III trial evaluating the intranasal CGRP receptor antagonist #Zavegepant for the acute treatment of #migraine headaches. Read more by @AyeshaR1202. https://buff.ly/3ER7Xju https://buff.ly/3ER7Xju" [X Link](https://x.com/Xtalks/status/1469434272499052550) 2021-12-10T22:30Z 26.2K followers, [--] engagements "In this previous podcast episode the editorial team discussed the encouraging growth seen in recent years in #raredisease clinical research and also talked about the underrepresentation of Black people in #clinicaltrials. Listen now to learn more https://buff.ly/3HXO7n8 https://buff.ly/3HXO7n8" [X Link](https://x.com/Xtalks/status/1512135753890942979) 2022-04-07T18:30Z 27.1K followers, [--] engagements "Hear about the shortage of GLP-1 diabetes drug Ozempic and the offering of free insulin by a fake Eli Lilly Twitter account. Listen now: #Insulin #Diabetes #EliLilly #NovoNordisk #Type2Diabetes https://buff.ly/3gnnMY2 https://buff.ly/3gnnMY2" [X Link](https://x.com/Xtalks/status/1594375233854574592) 2022-11-20T17:00Z 26.8K followers, [--] engagements "The FDA has approved Acadia Pharmaceuticals Daybue (trofinetide) as the first and only treatment for Rett syndrome a rare complex neurodevelopmental disorder that mainly affects girls. Read more here. #RareDisease #FDA #NeurologicalDisorder https://buff.ly/4025FbC https://buff.ly/4025FbC" [X Link](https://x.com/Xtalks/status/1645260310838759426) 2023-04-10T03:00Z 26.2K followers, [---] engagements "Allergan Aesthetics an @AbbVie company received FDA approval for a new skin product called SkinVive by Juvderm. To learn how SkinVive works and what its used for read more by Vincent Xie. #SkinCare #Dermatology #MedicalAesthetics" [X Link](https://x.com/Xtalks/status/1661402525524717569) 2023-05-24T16:03Z 27.4K followers, [--] engagements "Recently @abbvies Epkinly received #FDA approval for relapsed or refractory diffuse large B-cell #lymphoma (#DLBCL) in adult patients who have undergone at least two prior lines of therapy. Read more about the drug and rivals from @AyeshaR1202" [X Link](https://x.com/Xtalks/status/1662118972861317120) 2023-05-26T15:30Z 27.4K followers, [--] engagements "The FDA approved BioMarin Pharmaceutical's (BMRN.O) #genetherapy for severe hemophilia A the company said giving patients with the inherited bleeding disorder an alternative to regular injections of missing #bloodproteins. https://buff.ly/3CP9TcR https://buff.ly/3CP9TcR" [X Link](https://x.com/Xtalks/status/1676380501630763008) 2023-07-05T00:00Z 26.2K followers, [---] engagements "Pfizer recently launched a new TV commercial for its migraine medication Nurtec ODT featuring Grammy-winning artist Lady Gaga as the face of the campaign. #PharmaTVAds #Headache #Pfizer #Migraine #PharmaceuticalMarketing" [X Link](https://x.com/Xtalks/status/1678773679969427458) 2023-07-11T14:31Z 27.4K followers, [---] engagements "California-based @TarsusRx has secured FDA approval for its drug Xdemvy to treat Demodex blepharitis. Read more to learn how Xdemvy addresses the root cause of this widespread inflammatory eye condition. #FDA #EyeHealth #EyeDrops #Ophthalmology https://buff.ly/3E8NLed https://buff.ly/3E8NLed" [X Link](https://x.com/Xtalks/status/1689388641385078785) 2023-08-09T21:30Z 26.2K followers, [---] engagements "California-based Tarsus Pharmaceuticals Inc. a leader in developing #therapeutic solutions for common diseases with limited treatment alternatives has secured approval from the US #FDA for its #drug #Xdemvy. https://buff.ly/3E8NLed https://buff.ly/3E8NLed" [X Link](https://x.com/Xtalks/status/1692544412855808216) 2023-08-18T14:30Z 26.2K followers, [---] engagements "🔬 Exciting collaboration ICON plc is teaming up with the US Biomedical Advanced Research and Development Authority (BARDA) to conduct a clinical trial assessing the efficacy of next-gen #COVID19 #vaccines. https://buff.ly/468PlZb https://buff.ly/468PlZb" [X Link](https://x.com/Xtalks/status/1702472370282185099) 2023-09-15T00:00Z 27.1K followers, [---] engagements "Exciting news in healthcare @SmithRx_PBM partners with TheracosBio to improve patient access to the latest type [--] diabetes medication Brenzavvy via the Mark Cuban Cost Plus Drug Company platform Read more at by @dc_chandel15. #Diabetes #Type2Diabetes" [X Link](https://x.com/Xtalks/status/1704797850549338266) 2023-09-21T10:00Z 27.4K followers, [---] engagements "Gain insights from @Onchip_Bio_en into cell-free riboswitches their creation through microfluidic droplet sorting and their significance in facilitating intercellular communication. #GeneticEngineering #Genomics #RNA #Proteomics" [X Link](https://x.com/Xtalks/status/1707402439484219747) 2023-09-28T14:30Z 27.4K followers, [---] engagements "Join our enlightening webinar with @EmvenioResearch on leveraging tailored and scalable solutions for community engagement in clinical trials. 🌟 Register to learn more about how customized and scalable solutions can advance community engagement:" [X Link](https://x.com/Xtalks/status/1709259550526779657) 2023-10-03T17:30Z 27.5K followers, [---] engagements "AbbVie led pharma ad spending in August with three of its drugs taking the top spots. Read more about the top ten leading pharma TV ad spenders in August at by @AyeshaR1202" [X Link](https://x.com/Xtalks/status/1709508831712018930) 2023-10-04T10:00Z 27.4K followers, [---] engagements "🌟 Secure your spot in this webinar with @Avantor_News on lab inventory management digitization Learn about digital solutions that can help mitigate the challenges of modern-day lab inventory management to optimize and scale #LabOperations Register here:" [X Link](https://x.com/Xtalks/status/1710346764195103154) 2023-10-06T17:30Z 27.4K followers, [---] engagements "🌐 Join our upcoming webinar that delves into weight loss in the context of #MetabolicDisease and its connection to cutting-edge imaging technology. 🔍 Learn about #WeightLoss and the pivotal role of imaging in understanding metabolic disease: #PET" [X Link](https://x.com/Xtalks/status/1711388551395307910) 2023-10-09T14:30Z 27.4K followers, [---] engagements "💻 Join @OpenClinica for their upcoming webinar to learn how to realize long-term success with EHR eSource and real-world data across traditional decentralized virtual and digital-first clinical trials. 🚀 Register here: #ClinicalTrials #EDC #eSource" [X Link](https://x.com/Xtalks/status/1711411295033962713) 2023-10-09T16:00Z 27.4K followers, [---] engagements "Join our upcoming webinar with @PPDCRO to learn about EU & US #pharmacovigilance requirements for risk management in drug development. 🌐 We'll cover it all from identification to reporting 📢 Register here: #PatientSafety #PharmaceuticalRegulation" [X Link](https://x.com/Xtalks/status/1711774646259876253) 2023-10-10T16:04Z 27.4K followers, [---] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@Xtalks Xtalks Webinars
Xtalks Webinars posts on X about ipo, hosted, how can, health the most. They currently have [------] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.
Engagements: [---] #
- [--] Week [---] +22%
- [--] Month [-----] +153%
- [--] Months [------] +14%
- [--] Year [------] +106%
Mentions: [--] #
- [--] Week [--] +150%
- [--] Month [--] +154%
- [--] Months [---] +112%
- [--] Year [---] +187%
Followers: [------] #
- [--] Week [------] -0.02%
- [--] Month [------] -0.15%
- [--] Months [------] -0.77%
- [--] Year [------] -1.90%
CreatorRank: [---------] #
Social Influence
Social category influence stocks finance countries technology brands cryptocurrencies travel destinations celebrities exchanges social networks currencies
Social topic influence ipo, hosted, how can, health, data, ceo, how to, ai, novartis, acquisition
Top accounts mentioned or mentioned by @soumya2390 @ayeshar1202 @verakovacevic3 @cluepoints @miranabulsi123 @bioclinica @iconplc @thecantang @stagebiocro @premierresearch @synteract @syneoshealth @omnicommsystems @dcchandel15 @ppdcro @sydperelmutter @mercks @fortrea @abzenagroup @transperfect
Top assets mentioned Novartis AG (NVS) Eli Lilly and Company (LLY) Medtronic PLC (MDT) AbbVie Inc (ABBV) Sanofi (SNY) Vera Therapeutics, Inc. (VERA) CVS Health Corp (CVS) GLP1 (GLP1)
Top Social Posts
Top posts by engagements in the last [--] hours
"@WuXiBiologics a global company with leading open-access biologics technology platforms today announced that it has successfully completed both a Pre-License Inspection (PLI) and a routine GMP inspection by the @US_FDA. #Regulatory #Biologics #FDA https://buff.ly/3xmKdAr https://buff.ly/3xmKdAr"
X Link 2021-04-24T03:00Z 26.1K followers, [--] engagements
"Gene editing company CRISPR Therapeutics is expanding its research manipulating #genetic code to treat disease entering into an agreement with private company Capsida Biotherapeutics to collaborate on therapies for two #neurodegenerative disorders. https://buff.ly/3vDYSF1 https://buff.ly/3vDYSF1"
X Link 2021-06-24T18:30Z 26.1K followers, [--] engagements
".@Miro_Bio a #biotech company developing immune checkpoint agonists for #inflammatory and #autoimmunediseases is to be acquired by @GileadSciences for $405 million. Read more by @SaranyahKannuc1 to learn why Gilead will benefit from the acquisition. https://buff.ly/3p3HyZg https://buff.ly/3p3HyZg"
X Link 2022-08-09T21:30Z 26.1K followers, [--] engagements
"Register today Attendees will learn strategies to produce robust controlled-release tablets for the most challenging high-throughput commercial tableting conditions. #Formulation #DrugFormulation #Nitrosamines https://buff.ly/3TvXvWD https://buff.ly/3TvXvWD"
X Link 2023-04-04T00:00Z 26.1K followers, [---] engagements
"This weeks episode is about the Axonics Inc. non-drug implantable therapy for the treatment of bladder and bowel dysfunction and how AI can be used to study the side effects of drugs. Listen now: https://buff.ly/3M4EMOL https://buff.ly/3M4EMOL"
X Link 2023-05-08T22:03Z 26K followers, [---] engagements
"💊 @amicusrx1s Pombiliti + Opfolda is a new therapy for adults living with late-onset Pompe disease (#LOPD) who are not improving on their current enzyme replacement therapy. To learn more about the FDA approval for this rare disease read more at https://buff.ly/4a2jrQO https://buff.ly/4a2jrQO"
X Link 2023-12-01T14:01Z 26.1K followers, [---] engagements
"📰 Syneos Health has announced the appointment of Costa Panagos as its new CEO. Read more at by @AyeshaR1202 about Panagos who takes over from Colin Shannon the companys CEO following the companys acquisition by a consortium of private equity firms. https://buff.ly/3YgldsN https://buff.ly/3YgldsN"
X Link 2024-10-24T21:02Z 26K followers, [---] engagements
"❓ How can we reduce the burden of REMS programs on healthcare stakeholders Join Syneos Healths webinar to explore Health IT projects aimed at easing the load on prescribers and pharmacists with a more integrated automated REMS approach. Register now: https://buff.ly/3P1ZO2k https://buff.ly/3P1ZO2k"
X Link 2025-01-02T13:00Z 26K followers, [---] engagements
"Celltrions Avtozma has received FDA approval as a new biosimilar to Roches Actemra for indications including rheumatoid arthritis and COVID-19. Read more at by @AyeshaR1202 about Avtozma which is now the third approved Actemra biosimilar. https://buff.ly/4jIMDRX https://buff.ly/4jIMDRX"
X Link 2025-02-05T18:27Z 26.1K followers, [---] engagements
"The FDA has approved SpringWorks Therapeutics Gomekli (mirdametinib) for the treatment of the rare genetic disorder neurofibromatosis type [--] (NF1) in both adult and pediatric patients. Read more at by @AyeshaR1202. https://buff.ly/4jZ7hgz https://buff.ly/4jZ7hgz"
X Link 2025-02-14T14:49Z 26K followers, [---] engagements
"The FDA has approved Sanofis Merilog as the first rapid-acting insulin biosimilar. Merilog is a biosimilar to Novo Nordisks NovoLog and the third insulin biosimilar to receive approval to date. Read more at by @AyeshaR1202. https://buff.ly/4k6ERRZ https://buff.ly/4k6ERRZ"
X Link 2025-02-19T14:59Z 26.5K followers, [---] engagements
"❓ How can effective labeling strategies improve lab efficiency Join Computype and Thermo Fishers webinar to explore how reliable labeling can streamline accessioning and reduce errors. Register now: #Labware #LabelingStrategies #LabEfficiency https://buff.ly/3XkfD8T https://buff.ly/3XkfD8T"
X Link 2025-02-26T19:12Z 26.5K followers, [---] engagements
"Roche and Zealand Pharma are teaming up in a $5.3B deal to co-develop petrelintide a next-gen obesity therapy. With potential for best-in-class efficacy and a novel combo approach learn more about this major move by @soumya2390 at https://buff.ly/AhKmTKW https://buff.ly/AhKmTKW"
X Link 2025-03-18T11:27Z 26K followers, [---] engagements
"❓ How can AI-powered tools optimize pharmacovigilance workflows Join Syneos Healths webinar to discover how AI-driven case processing is transforming drug safety management. Register now: #AI #DrugSafety #Pharmacovigilance #Webinar #LifeSciences https://buff.ly/qjJwmkA https://buff.ly/qjJwmkA"
X Link 2025-04-04T10:44Z 26K followers, [---] engagements
"Novartiss newly approved Vanrafia (atrasentan) cut proteinuria by over 36% in a Phase III trial in patients with primary IgA nephropathy. Discover more about the oncedaily oral therapy in our latest article by @soumya2390 at https://buff.ly/CoHdaK5 https://buff.ly/CoHdaK5"
X Link 2025-04-10T13:19Z 26.1K followers, [---] engagements
"Terumo Neuro has received FDA premarket approval (PMA) for its latest Carotid Stent system which the company says is the first dual-layer micromesh carotid stent approved in the US. Read more at by @AyeshaR1202. https://buff.ly/03Fptjh https://buff.ly/03Fptjh"
X Link 2025-04-28T14:18Z 26K followers, [---] engagements
"In this episode hear from OS Therapies CEO Paul Romness about how the company is advancing innovative immunotherapies in cancers like osteosarcoma. Listen now at https://buff.ly/GLI4JWk https://buff.ly/GLI4JWk"
X Link 2025-05-02T13:55Z 26K followers, [---] engagements
"❓ How can bakeries meet rising consumer demands for healthier functional and sustainable products Join Brenntags webinar to explore egg replacements sugar reduction and clean label innovations. Register now: #BakingIndustry #FoodInnovation #Sustainability #Brenntag https://buff.ly/RA4OuiI https://buff.ly/RA4OuiI https://buff.ly/RA4OuiI https://buff.ly/RA4OuiI"
X Link 2025-05-27T14:22Z 26.1K followers, [---] engagements
"June [--] was the first-ever #FSGSAwarenessDay. Travere Therapeutics' #PlayItForwardFSGS campaign led by artists Brian Kennedy & David Rush celebrates creativity in the FSGS community and invites others to share their stories. Read more at #RareKidneyDisease #FSGS #PatientVoices #TravereTherapeutics. https://buff.ly/yDehMsh https://buff.ly/yDehMsh https://buff.ly/yDehMsh https://buff.ly/yDehMsh"
X Link 2025-06-13T19:31Z 26K followers, [---] engagements
"The FDA has approved Nuvation Bios Ibtrozi for advanced ROS1+ NSCLC. The drug shows strong intracranial efficacy and durable responses which could help the next-gen TKI shift the treatment landscape that is currently led by TKIs from Pfizer BMS and Roche. Read more at https://buff.ly/Nhdiq0R https://buff.ly/Nhdiq0R"
X Link 2025-06-18T13:36Z 26K followers, [---] engagements
"❓ Is your early phase oncology trial ready for FDAs Project Optimus Join Syneos Health's webinar with Wael Harb MD X.Q. Xue and Patrick Melvin as they explore how Project Optimus is reshaping early phase oncology trials. Learn how to design smarter trials that meet FDA expectations while reducing regulatory risk and accelerating development. Register now: #OncologyTrials #FDA #ClinicalTrials #DoseOptimization #SyneosHealth https://buff.ly/7kqzM92 https://buff.ly/7kqzM92"
X Link 2025-06-30T14:17Z 26K followers, [---] engagements
"argenx debuts two new Vyvgart Hytrulo TV ads focused on self-injection flexibility and personalized generalized myasthenia gravis (gMG) care. Explore more about these campaigns at by @soumya2390. #VyvgartHytrulo #argenx #gMG #MyastheniaGravis #AutoimmuneTreatment #TVAds #DTCA #SubcutaneousTherapy #PatientAutonomy #AtHomeTreatment #FcRnBlocker #SelfInjection https://buff.ly/FYi1E8P https://twitter.com/i/web/status/1949910082143080790 https://buff.ly/FYi1E8P https://buff.ly/FYi1E8P https://twitter.com/i/web/status/1949910082143080790 https://buff.ly/FYi1E8P"
X Link 2025-07-28T19:09Z 26K followers, [---] engagements
"With promising Phase III data gefurulimab joins the conversation on next-gen biologics in generalized myasthenia gravis (gMG). We explore the trial outcomes and more at by @soumya2390. #AstraZeneca #Alexion #Gefurulimab #MyastheniaGravis #gMG #Nanobody #PhaseIII #PREVAILtrial #Neurology #RareDisease #AutoimmuneDisease #FcRn #C5Inhibitor #Vyvgart https://buff.ly/X0OSaDq https://buff.ly/X0OSaDq https://buff.ly/X0OSaDq https://buff.ly/X0OSaDq"
X Link 2025-08-01T18:55Z 26.1K followers, [---] engagements
"PTC Therapeutics Sephience (sepiapterin) gets the FDA green light for treating all PKU subtypes. Learn how this oral therapy expands options for managing BH4-responsive PKU by @soumya2390 at #Phenylketonuria #PKU #Sepiapterin #BH4Pathway #RareDisease #OrphanDrugs #PTCTherapeutics #FDAApproval #DrugDevelopment #EnzymeTherapy #MetabolicDisorders https://buff.ly/dYbAtPS https://buff.ly/dYbAtPS https://buff.ly/dYbAtPS https://buff.ly/dYbAtPS"
X Link 2025-08-04T10:57Z 26K followers, [---] engagements
"Today were highlighting Xtalks Featured Community Member Dr. Marissa Halfin MD MBA Director of Clinical Informatics at Labcorp. With a strong focus on integrating AI and real-world evidence (RWE) generation into clinical research she is helping modernize how evidence is generated and used to advance patient care. Dive into her story at https://buff.ly/DwkvMOm https://buff.ly/DwkvMOm"
X Link 2025-08-19T10:19Z 26K followers, [---] engagements
"In this episode Galderma US VP Medical Affairs Dr. Bill Andriopoulos discusses innovations in dermatology to advance care for every skin story. Listen now at 🎙 https://buff.ly/dX6eh47 https://buff.ly/dX6eh47"
X Link 2025-09-04T14:23Z 26.1K followers, [--] engagements
"❓ How can clinical trials for rare respiratory diseases be faster and more effective Join Francis Jones Terri Denissen Alex Auais and Gino Pirri from Thermo Fisher Scientific to explore how AI real-world data and strategic trial design are overcoming challenges in idiopathic pulmonary fibrosis (IPF) and other rare respiratory diseases. Learn how innovations in patient recruitment retention and trial execution improve outcomes and accelerate development. Register now: #ClinicalTrials #RareDisease #PatientRecruitment #AIinHealthcare #ThermoFisher #PPD https://buff.ly/CQAOZx9"
X Link 2025-09-10T10:33Z 26.1K followers, [---] engagements
"The FDA has approved Inluriyo (imlunestrant) an oral estrogen receptor antagonist for adults with ER+/HER2 ESR1-mutated advanced breast cancer. Learn about the trial data in our latest article at by @soumya2390. #Inluriyo #Imlunestrant #EliLilly #FDAApproval #BreastCancer #MetastaticBreastCancer #AdvancedBreastCancer #ERPositive #HER2Negative #ESR1Mutation #Oncology https://buff.ly/t8y63uM https://buff.ly/t8y63uM https://buff.ly/t8y63uM https://buff.ly/t8y63uM"
X Link 2025-10-01T16:31Z 26.1K followers, [---] engagements
"Were excited to share our video highlights from the @kpmorgangroup 9th Annual Operational Excellence in Clinical Trials (OECT) Summit in Toronto As the official Media Partner Xtalks was proud to capture key discussions on regulatory updates patient recruitment data quality and the future of clinical research. A special thanks to the clinical research experts who joined Xtalks for video interviews at the Summit: Tania Azad Global Program Director Late Phase Clinical Operations Alexion Pharmaceuticals Andrea Bastek PhD VP Market Strategy Florence Healthcare Kevin Lin MBA MSc Director Innovative"
X Link 2025-10-03T14:11Z 26.1K followers, [--] engagements
"Healthcare mergers and acquisitions in [----] continue to reshape the industry from hospital and behavioral health integrations to AI-powered platforms and payer-provider partnerships. Explore the latest deals transforming care delivery financing and digital health by @soumya2390 at #HealthcareMergers #HealthcareAcquisitions #HealthcareM&A #HealthcareDeals #HealthcareIndustry #HealthcareInnovation #HealthcareTrends #HospitalMergers https://buff.ly/vDiO2uS https://buff.ly/vDiO2uS"
X Link 2025-10-08T14:54Z 26.1K followers, [---] engagements
"❓ How can we accelerate pediatric clinical trials in oncology and hematology Join Thermo Fisher Scientific for a webinar with Charity Schuller PharmD MS RAC Mariana Burin MD Marcie Weil MD Sheree Gilmore and Sush Sankpal MD to explore strategies for overcoming enrollment challenges regulatory hurdles and equity gaps in pediatric cancer trials. Learn how innovative approaches in gene and cellular therapies are shaping the next generation of pediatric clinical research. Register now: #PediatricTrials #OncologyResearch #Hematology #ClinicalTrials #ThermoFisherScientific https://buff.ly/TcSX5RF"
X Link 2025-10-15T10:12Z 26.1K followers, [--] engagements
"❓ How can patient recruitment and site support reduce trial dropout Join SubjectWell for a webinar with Samantha Schmidt Richard Towne and Stacia Wilson to explore how optimizing the patient journey and site support can improve retention and trial success. The discussion will highlight real-world site challenges best practices for integrated patient and site support and strategies to maintain engagement during periods when sites are slower such as holidays. Register now: #ClinicalTrials #PatientRecruitment #TrialRetention #PatientExperience #SubjectWell https://buff.ly/HPPditr"
X Link 2025-10-17T10:27Z 26.1K followers, [--] engagements
"🚀 How can early medical information planning improve biotech product launch success Join Thermo Fisher Scientific for a webinar with Graham Harding and Dominique Van Hoese on how biotech teams can use medical information as a strategic driver during launch preparation not just a compliance requirement. The session will cover how proactive medical information strengthens cross-functional alignment mitigates risk supports scalability and enhances customer experience. Register now: #BiotechLaunch #MedicalInformation #RegulatoryStrategy #LifeSciences #ThermoFisherScientific"
X Link 2025-10-21T10:45Z 26.1K followers, [---] engagements
"❓ How can regulatory teams accelerate document generation without compromising security or accuracy Join ZYLIQ for a webinar with Mark Pittman to explore how closed-loop generative AI (Gen-AI) is reshaping regulatory writing. Discover how secure purpose-built AI systems can streamline the creation of safety narratives clinical study reports and other critical documents while maintaining full data protection and compliance. Register now: #RegulatoryWriting #AIinLifeSciences #ClinicalTrials #Automation #ZYLIQ https://buff.ly/whrxmjP https://buff.ly/whrxmjP"
X Link 2025-10-22T13:00Z 26.1K followers, [--] engagements
"Keytruda Qlex brings a subcutaneous version of pembrolizumab to [--] solid tumor indications with the same efficacy and one- to two-minute administration. Our latest article breaks down trial data and more at by @soumya2390. #KeytrudaQlex #Merck #FDAApproval #Immunotherapy #CancerCare #Oncology #CheckpointInhibitor #PD1 #Pembrolizumab #SubcutaneousInjection #Biopharma https://buff.ly/fKBM1c1 https://buff.ly/fKBM1c1 https://buff.ly/fKBM1c1 https://buff.ly/fKBM1c1"
X Link 2025-10-23T17:22Z 26.1K followers, [---] engagements
"❓ How can precision medicine and patient-centric trial design solve the challenges of clinical research for older adults with neurological diseases Join Thermo Fisher Scientific Inc. for a critical webinar featuring Panos Papanastasopoulos Debra Schaumberg ScD OD MPH John Hamlet Sabine Krofczik-Wilhelm PhD and Alberto Lled MD PhD. They will explore how sub-classifying complex conditions with disease-specific biomarkers and integrating the real-world needs of aging populations can make trials more precise and equitable especially for advanced therapies like cell and gene therapies. Register"
X Link 2025-10-28T14:04Z 26.1K followers, [---] engagements
"❓ Are slow planning cycles fragmented data and manual processes hindering your clinical trial delivery Join Tim Mudric and Dave Hiltbrand from Thermo Fisher Scientific to explore how Artificial Intelligence (AI) is transforming trial operations. Learn how prioritizing interoperable systems and collaboration can help your organization fully leverage AIs potential for operational excellence. Broadcast [--] (EMEA): 2:30 PM GMT / 3:30 PM CET Broadcast [--] (North America): [--] PM EST / [--] AM PST #ClinicalTrials #ArtificialIntelligence #AIDriven #DigitalTransformation #ClinicalResearch"
X Link 2025-10-29T15:08Z 26.1K followers, [--] engagements
"@M4Knicks Eric Robbibaro shares how continuous conductivity monitoring goes beyond compliance: it protects patients improves efficiency and supports sustainability in pharma manufacturing. Watch the Spotlight video and read the full article at 🎙 #PharmaceuticalManufacturing #DrugManufacturing #Conductivity #Compliance #LifeSciences #Biopharma #XtalksSpotlight #M4Knick https://buff.ly/FI8MWYo https://buff.ly/FI8MWYo https://buff.ly/FI8MWYo https://buff.ly/FI8MWYo"
X Link 2025-10-30T10:14Z 26.1K followers, [--] engagements
"Waves of layoffs continue in pharma and biotech this year. From Moderna and Novo Nordisk to Genentech and BlueRock Therapeutics [----] has brought sweeping workforce reductions across the life sciences sector. Read more #PharmaLayoffs #BiotechLayoffs #Layoffs https://buff.ly/EPFTyMG https://buff.ly/EPFTyMG https://buff.ly/EPFTyMG https://buff.ly/EPFTyMG"
X Link 2025-11-03T15:42Z 26.1K followers, [--] engagements
"🔁 Friday Rewind with Xtalks From sleep health campaigns to AI-powered acquisitions and new nonhormonal options for menopause treatment heres what moved the week. 😴 OSA Highlight: Lilly x Shaq Team Up on Awareness See the campaign: 📊 Poll: Which Emerging Tech Will Reshape Trials by [----] Cast your vote: 🤝 Thermo Fisher to Acquire Clario for $9.4B Scan the deal terms: 🧪 Saliva-Based Oral HPV Test Debuts Check how it works: 🌸 Bayers Lynkuet Enters US Menopause Market (Nonhormonal) Compare options: Life Sciences Central: A New Canada-Wide Pathway Explore the new hub: 🧬 Blenrep Combo"
X Link 2025-11-03T15:44Z 26.1K followers, [--] engagements
"Major pharma and biotech M&As are continuing into the latter half of [----] with big moves from big players like Thermo Fisher Novartis and Eli Lilly this month. Find out about the latest pharma deals at #PharmaMergersAndAquisitions #PharmaAcquisitions #BiotechAcquisitions #PharmaDeals https://buff.ly/WVl3qVu https://buff.ly/WVl3qVu https://buff.ly/WVl3qVu https://buff.ly/WVl3qVu"
X Link 2025-11-03T16:49Z 26.1K followers, [--] engagements
"Learn from Dr. Rebecca Abram PhD Director of Global Strategic Technical Marketing at FUJIFILM Biotechnologies about the future of conjugation and PEGylation in biologics with advancements focused on enhancing drug efficacy and reducing immunogenicity. Read more at https://buff.ly/rKy0dgU https://buff.ly/rKy0dgU"
X Link 2025-11-03T20:08Z 26.1K followers, [---] engagements
"Novo Nordisk has launched a bidding war with Pfizer for obesity biotech Metsera. The showdown is underway as both pharma giants race to expand their GLP-1 pipelines. Read more at #ObesityDrugs #MergersAndAcquisitions #NovoNordisk #Pfizer https://buff.ly/gMm2oEa https://buff.ly/gMm2oEa"
X Link 2025-11-04T18:49Z 26.1K followers, [---] engagements
"Join Ian Brown PhD from FUJIFILM Biotechnologies to learn how biopharma companies can implement 'Acceleration Levers' to reduce delays and optimize timelines in late-phase chemistry manufacturing and controls (CMC) programs for therapeutic proteins. In this webinar Ian will discuss strategies to streamline CMC activities across mammalian and microbial systems define what an acceleration lever is and explore key approaches for improving efficiency and success in therapeutic protein development. Register here: #CMC #Biopharma #TherapeuticProteins #ProcessDevelopment #AccelerationLevers"
X Link 2025-11-05T11:57Z 26.1K followers, [---] engagements
"Amgens new Otezla TV ad features a karaoke-night scenario to highlight the social impact of plaque psoriasis with a focus on quality of life earlier-stage treatment options and patient empowerment. Read more at #PsoriasisAwareness #Dermatology #PharmaMarketing #PatientCentricity #Otezla #Amgen https://buff.ly/GVkpGi6 https://buff.ly/GVkpGi6 https://buff.ly/GVkpGi6 https://buff.ly/GVkpGi6"
X Link 2025-11-06T22:18Z 26.1K followers, [---] engagements
"Eli Lilly and Novo Nordisk have struck deals with the Trump administration to reduce the monthly costs of GLP-1 weight loss medications which will be available through the new TrumpRx platform and expanded Medicare/Medicaid coverage. Read more at #DrugPricing #DrugPriceNegotiations #GLP1Drugs #ObesityDrugs #EliLilly #NovoNordisk https://buff.ly/pbPaR3Y https://buff.ly/pbPaR3Y https://buff.ly/pbPaR3Y https://buff.ly/pbPaR3Y"
X Link 2025-11-07T20:57Z 26.1K followers, [---] engagements
"Galdermas Dr. Bill Andriopoulos shares how clinical innovation long-term data and patient perspectives are transforming dermatological research and care in this Xtalks Clinical Edge interview. Read here: #XtalksClinicalEdge #ClinicalResearch #ClinicalTrials #Dermatology #Skin #AtopicDermatitis #Eczema https://buff.ly/NJBtpIp https://buff.ly/NJBtpIp https://buff.ly/NJBtpIp https://buff.ly/NJBtpIp"
X Link 2025-11-10T11:10Z 26K followers, [--] engagements
"Hear from Sara Bursomanno PhD and Chantale Julien from Novo as they tackle the critical issue of ensuring compliance and high performance using animal-free raw materials in CGT manufacturing. Discover validated recombinant solutions that meet stringent regulatory requirements and significantly boost key metrics like AAV titer and cell viability. Don't miss this opportunity to optimize your workflow and ensure product consistency and patient safety. Register now: #CellAndGeneTherapy #AnimalFree #CGTManufacturing https://buff.ly/AJ2Z3px https://buff.ly/AJ2Z3px"
X Link 2025-11-10T11:33Z 26.1K followers, [--] engagements
"With facilities and equipment designed for fast adaptability learn how FUJIFILM Biotechnologies can scale manufacturing operations in response to both product and market requirements whether by increasing capacity or shifting production strategies. Read more at #Biologics #Biomanufacturing #Biopharma https://buff.ly/mJRB2pa https://buff.ly/mJRB2pa"
X Link 2025-11-10T14:30Z 26.1K followers, [--] engagements
"Palo Alto California biotech Evommune is set to bring fresh momentum to chronic inflammation research. The $150M IPO will advance oral and injectable therapies that target diseases like urticaria and dermatitis. Learn more at by @soumya2390. #EvommuneIPO #InflammationResearch #AtopicDermatitis #BiotechNews #Immunology https://buff.ly/wqbZUTi https://buff.ly/wqbZUTi https://buff.ly/wqbZUTi https://buff.ly/wqbZUTi"
X Link 2025-11-10T14:42Z 26.1K followers, [--] engagements
"Pfizer has lost its court bid to block Novo Nordisks counteroffer for the obesity drug biotech. Read more at #Pfizer #NovoNordisk #Metsera #ObesityDrugs #PharmaLawsuit https://buff.ly/eelIzJk https://buff.ly/eelIzJk"
X Link 2025-11-10T14:45Z 26.1K followers, [--] engagements
"Uncover the emerging trends driving the future of cancer care with Dr. Jozsef Palatka MD Dr. Rob Berg MD PhD and Marek Rombel from Syneos Health. Learn which cutting-edge treatment modalities from evolving immuno-oncology to next-wave Antibody-Drug Conjugates (ADCs) are capturing oncologists' attention and reshaping the standard of care. Register to gain insights on how new clinical signals influence commercialization trial design and pipeline prioritization strategies: #Oncology #ClinicalTrials #DrugDevelopment https://buff.ly/VggxfeE https://buff.ly/VggxfeE"
X Link 2025-11-12T11:03Z 26K followers, [---] engagements
"For millions dry eye disease feels like having an eyelash in your eye every hour of every day with no relief. Elizabeth Jeffords CEO of Iolyx Therapeutics shares how understanding patient experience and autoimmune drivers is reshaping treatment approaches for this overlooked condition. Read more in this Xtalks Clinical Edge interview at by Mohammad Ali. #Ophthalmology #DryEyeDisease #XtalksClinicalEdge #IolyxTherapeutics #ClinicalResearch https://buff.ly/52Y0kQb https://buff.ly/52Y0kQb"
X Link 2025-11-12T11:21Z 26.1K followers, [--] engagements
"New Phase III data spotlight Mercks enlicitide decanoates once-daily oral approach to LDL-C reduction. Our article unpacks key lipid results and what comes next for this investigational PCSK9 inhibitor at by @soumya2390. #Merck #Cholesterol #Hypercholesterolemia #CardiovascularHealth #PCSK9 https://buff.ly/9lcOTec https://buff.ly/9lcOTec https://buff.ly/9lcOTec https://buff.ly/9lcOTec"
X Link 2025-11-13T15:07Z 26.1K followers, [---] engagements
"Recent weeks brought more workforce shifts in medtech with Olympus Abbott Medtronic and Philips all announcing job cuts. See whos been added to our Medtech Layoffs [----] roundup by @soumya2390 at #MedTechLayoffs #MedicalDevices #MedTechNews #WorkforceTrends https://buff.ly/TEhtTHd https://buff.ly/TEhtTHd https://buff.ly/TEhtTHd https://buff.ly/TEhtTHd"
X Link 2025-11-13T15:08Z 26.1K followers, [--] engagements
"@clinicaltrialON [----] brought together researchers regulators industry leaders and patients to reimagine efficiency ethics and access in Canadas clinical trial ecosystem. Xtalks spoke with Dr. PJ Devereaux Susan Marlin Matt Westmore Ramy Nassar Dr. Sowmya Viswanathan and Donna Janzen who shared their perspectives on navigating and driving efficient patient-centered research in Canada. Read our full post-event recap @soumya2390 at A special thank you to Elise Johnson and everyone at Clinical Trials Ontario for organizing #CTO2025. #ClinicalTrialsOntario2025 #ClinicalResearch #AIinHealthcare"
X Link 2025-11-13T16:25Z 26.1K followers, [--] engagements
"Eli Lilly has partnered with Tan France from Netflix's Queer Eye on its new Changing the Thread Collection Zepbound campaign that weaves together fashion storytelling and science to challenge obesity stigma. Read more at #EliLilly #Zepbound #TanFrance #ObesityAwareness #PatientVoice #PharmaMarketing https://buff.ly/i0ey1HH https://buff.ly/i0ey1HH https://buff.ly/i0ey1HH https://buff.ly/i0ey1HH"
X Link 2025-11-13T21:23Z 26K followers, [---] engagements
"Vote and see results in our latest Xtalks Life Science Poll: What technology do you think will transform clinical trials by [----] the most AI decentralized trial platforms wearables or real-world data (RWD) integration Vote and see results here: #ClinicalTrials #DigitalHealth #Pharma #Biotech #DCT #RWD #Wearables https://buff.ly/KAdRX44 https://buff.ly/KAdRX44 https://buff.ly/KAdRX44 https://buff.ly/KAdRX44"
X Link 2025-11-14T11:48Z 26.1K followers, [---] engagements
"Gain insights into addressing the complexities of large-scale cGMP viral vector manufacturing while meeting required quality standards with FUJIFILM Biotechnologies. Read more at #Biologics #CGT #CellandGeneTherapy #ViralVectors https://buff.ly/lpTYusa https://buff.ly/lpTYusa"
X Link 2025-11-17T14:30Z 26.1K followers, [---] engagements
"Register now to join Dr. John A. Karas Dr. Linda Haugaard-Kedstrm and Samuel J. Paravizzini PhD Candidate from PolyPeptide Group for a deep dive into advanced solid-phase peptide synthesis (SPPS) strategies. They will explore how innovative backbone protecting groups can overcome chain insolubility and aggregation issues that hamper yield and lead to inseparable deletion impurities. Sign up to learn the state-of-the-art methods for improving synthetic efficiency and product quality in complex peptide manufacturing: #PeptideSynthesis #SPPS #PeptideChemistry https://buff.ly/GcIDyxh"
X Link 2025-11-18T16:50Z 26.1K followers, [--] engagements
"Explore cutting-edge strategies for tackling peptide degradation with Elizabeth Denton PhD and Caroline Proulx PhD from Biotage. They will reveal how replacing the alpha carbon to create azapeptides alters conformation and facilitates the creation of large libraries overcoming common degradation challenges in drug design. Register to gain critical insights into new synthesis techniques and address the real-world difficulties of automated complex peptide chemistry workflows: #DrugDesign #Azapeptides https://buff.ly/cMq99Jw https://buff.ly/cMq99Jw"
X Link 2025-11-18T20:49Z 26.1K followers, [---] engagements
"Learn how bioinformatics contributes to in silico manufacturability assessments by Arghya Barman from FUJIFILM Biotechnologies. Read more at #Bioinformatics #Biologics #Biomanufacturing #Biopharma https://buff.ly/t4OZVRc https://buff.ly/t4OZVRc"
X Link 2025-11-24T14:30Z 26.1K followers, [---] engagements
"Join Dr. Sayna Norouzi Dr. Hannah Troutman and Sarah Dixon Stump for a webinar hosted by Thermo Fisher Scientific Inc to learn how polycystic kidney disease (PKD) clinical trials are shaping the future of ADPKD treatment. They will explore the clinical landscape factors to consider for clinical trials and emerging therapeutic targets like serum proteomics and ciliopathies. Register now to gain essential insights into addressing the urgent need for new effective treatments for this leading cause of genetic kidney failure: #PKD #ADPKD #ClinicalTrials https://buff.ly/MNz3IEt"
X Link 2025-11-24T16:32Z 26.1K followers, [--] engagements
"The FDA has approved Kyowa Kirin and Kura Oncologys jointly developed menin inhibitor Komzifti for relapsed or refractory NPM1-mutated AML. The approval comes just a month after Syndax Pharma's Revuforj was approved as the first-in-class menin inhibitor in the indication. Read more at #AcuteMyeloidLeukemia #AML #Hematology #PrecisionMedicine #Pharma #OncologyDrugs https://buff.ly/Szm6hLa https://buff.ly/Szm6hLa"
X Link 2025-11-24T17:58Z 26.1K followers, [---] engagements
"Were thrilled to celebrate and acknowledge the professionals driving innovation research and impact across life sciences in our next group of Xtalks Featured Community Members: Ankur Dnyanmote PhD Medical Writer Thermo Fisher Scientific Charles Legg Chair Global Advisory Board The Health Pals Company Giselle Della Rosa MSc Epidemiologist ACUMAR Per Rigler PhD Product Manager Bhlmann Laboratories AG Shazia Khan MSc Bioinformatician Life Science Researcher and Advocate for Women in STEM Srividya Narayanan MDS MS SaMD Regulatory Researcher Freyr Solutions Meet them all at and learn how to apply"
X Link 2025-11-25T14:27Z 26K followers, [--] engagements
"Unify your fragmented data and drive precision across the pharma value chain with Skye Hodson PhD and Ritupriya Yamujala in this webinar hosted by Citeline. They will demonstrate how a single connected ecosystem blending clinical RWE and market data augmented by trustworthy AI uncovers hidden patterns and accelerates critical decisions. Register now for the blueprint on optimizing protocol design accelerating recruitment and strengthening market forecasting from pipeline to patient: #PharmaData #TrustworthyAI #ClinicalTrials https://buff.ly/IijrRB1 https://buff.ly/IijrRB1"
X Link 2025-11-25T14:59Z 26.1K followers, [--] engagements
"FibroBiologics CEO Pete OHeeron and CSO Dr. Hamid Khoja share how fibroblast-based therapies may unlock new possibilities for immune modulation wound healing and longevity. Read more in this Xtalks Clinical Edge interview at by @VeraKovacevic3. #XtalksClinicalEdge #FibroBiologics #Fibroblasts https://buff.ly/I5jEn9O https://buff.ly/I5jEn9O https://buff.ly/I5jEn9O https://buff.ly/I5jEn9O"
X Link 2025-11-26T11:12Z 26.1K followers, [---] engagements
"The FDA has approved Novartis intrathecal SMA gene therapy Itvisma expanding gene therapy access for both pediatric and adult patients. Read more at including its $2.59M list price and multibillion-dollar peak sales projections. #GeneTherapy #RareDisease #SMA #Novartis https://buff.ly/5gLnKbI https://buff.ly/5gLnKbI https://buff.ly/5gLnKbI https://buff.ly/5gLnKbI"
X Link 2025-11-26T15:48Z 26.1K followers, [---] engagements
"In this episode hear from respiratory disease researcher and severe asthma expert Dr. Andrew Menzies-Gow from AstraZeneca about the latest innovations in respiratory and immunology drug development. Listen now at 🎙 https://buff.ly/DYVwKEn https://buff.ly/DYVwKEn"
X Link 2025-11-26T18:57Z 26.1K followers, [--] engagements
"From AI-enabled pre-screening to ultra-compact wearables and adaptive Phase III designs clinical trials evolved fast in [----]. Heres how these shifts are setting the tone for clinical trial trends in [----] at by @soumya2390. #ClinicalTrials2026 #DecentralizedTrials #DigitalBiomarkers #RWE #LifeSciences https://buff.ly/j7PWZvE https://buff.ly/j7PWZvE https://buff.ly/j7PWZvE https://buff.ly/j7PWZvE"
X Link 2025-11-26T19:00Z 26.1K followers, [--] engagements
"Navigate the inevitable disruptions in open claims data with Ramachandra (Ram) Bendre and Stephen Bielecki in this webinar hosted by ICON. They will demonstrate how thoughtful proactive management of these powerful datasets is essential for life sciences organizations to preserve analytical value and maintain a strategic advantage. Register now to learn how to anticipate interpret and adapt to shifts in open-sourced data with confidence: #ClaimsData #LifeSciences #DataStrategy https://buff.ly/UHlsmFW https://buff.ly/UHlsmFW"
X Link 2025-11-27T11:38Z 26.1K followers, [--] engagements
"Join Dr. Sayna Norouzi Dr. Hannah Troutman and Sarah Dixon Stump for a webinar hosted by Thermo Fisher Scientific Inc to learn how polycystic kidney disease (PKD) clinical trials are shaping the future of ADPKD treatment. They will explore the clinical landscape factors to consider for clinical trials and emerging therapeutic targets like serum proteomics and ciliopathies. Register now to gain essential insights into addressing the urgent need for new effective treatments for this leading cause of genetic kidney failure: #PKD #ADPKD #ClinicalTrials https://buff.ly/MNz3IEt"
X Link 2025-11-27T15:07Z 26K followers, [---] engagements
"Novo Nordisks Phase III evoke trials tested oral semaglutide in early Alzheimers disease. The drug did not slow clinical decline over two years. In our article we unpack the trial results safety findings and more at by @soumya2390. #NovoNordisk #AlzheimersDisease #Semaglutide #Neuroscience https://buff.ly/wmKeBuO https://buff.ly/wmKeBuO https://buff.ly/wmKeBuO https://buff.ly/wmKeBuO"
X Link 2025-11-28T17:47Z 26.1K followers, [---] engagements
"Gain insights from Michael Baker from FUJIFILM Biotechnologies about how expertise in oncolytic virus (OV) production cell culture and validation-level analytics can be hugely advantageous for OV developers looking to bring their products to market. Read more at #OncolyticVirus #OncolyticVirusTherapy #CellCulture #CellandGeneTherapy https://buff.ly/NTywlR7 https://buff.ly/NTywlR7"
X Link 2025-12-01T14:30Z 26.1K followers, [--] engagements
"Meet Xtalks Featured Community Member Ankur Dnyanmote PhD Medical Writer at Thermo Fisher Scientific. With two decades of research experience he is pioneering the integration of generative AI in medical writing to enhance the creation of clinical and regulatory documents. Read his story at #LifeSciences #MedicalWriting #AIinScience #Regulatory #ClinicalResearch https://buff.ly/7AeGtMQ https://twitter.com/i/web/status/1995817991338877267 https://buff.ly/7AeGtMQ https://twitter.com/i/web/status/1995817991338877267"
X Link 2025-12-02T11:31Z 26K followers, [--] engagements
"Pfizer's acquisition of obesity biotech Metsera after a fierce battle with Novo Nordisk dominated the M&A headlines in pharma last month. Other notable M&As in November included Merck's buyout of Cidara for a flu asset and J&J's bet on oncology assets from Halda. Read more at by @AyeshaR1202. https://buff.ly/alUD2Lv https://buff.ly/alUD2Lv"
X Link 2025-12-03T14:41Z 26.1K followers, [---] engagements
"FDA approves Voyxact for IgA nephropathy (IgAN) the first biologic and first-in-class APRIL-targeting therapy approved for the rare kidney disease. Read more at about a class and space that may see increasing competition soon. #FDA #DrugApproval #Biotech #Pharma #IgAN #RareDisease #Nephrology #KidneyHealth #ClinicalResearch https://buff.ly/kMskSYw https://buff.ly/kMskSYw https://buff.ly/kMskSYw https://buff.ly/kMskSYw"
X Link 2025-12-03T14:44Z 26.1K followers, [---] engagements
"Notable workforce reductions in pharma & biotech continue as the year winds down. From Novartis cutting over [---] jobs to Catalent bringing its workforce down by several hundred and AbbVie ending its high profile partnership with Alphabet-owned Calico learn about the latest layoffs in pharma & biotech. Read more at by @AyeshaR1202. https://buff.ly/jwJYw9C https://buff.ly/jwJYw9C"
X Link 2025-12-04T19:15Z 26.1K followers, [---] engagements
"Strengthen your mRNA therapeutics program from the sequence level up with experts Jessica Madigan Manika Bhondeley PhD and Molly McGlaughlin in this webinar hosted by BIOVECTRA. They will examine how rational sequence engineering including codon optimization and UTR selection shapes expression manufacturability and reduces development risk from design to GMP production. Register now to gain actionable insights on aligning sequence attributes with real-world process capabilities IVT yield and regulatory readiness for smoother development and tech transfer: #mRNATherapeutics #GMPManufacturing"
X Link 2025-12-05T11:01Z 26.1K followers, [--] engagements
"Explore the practical implications of the new ICH GCP E6 (R3) Guideline with Jo Hulbert and Jo Sprague in this webinar hosted by ICON. They will explain the major structural and content changes outlining how the shift to a risk-based approach impacts sponsors investigators and service providers globally. Register now to gain practical steps for comparing R2 and R3 updating procedures and executing successful implementation across all functions: #ICHGCP #ClinicalTrials #RegulatoryCompliance https://buff.ly/cCA3PId https://buff.ly/cCA3PId"
X Link 2025-12-05T11:58Z 26.1K followers, [--] engagements
"As demand for biologic medications grows global shortages loom over developers seeking to provide a reliable supply to patients in need. Learn about innovative strategies to build more resilient supply chains mitigate risk and prevent potential shortages by FUJIFILM Biotechnologies. Read more at #Biologics #Biopharma #Biomanufacturing https://buff.ly/e5NXCDf https://buff.ly/e5NXCDf"
X Link 2025-12-08T14:26Z 26.1K followers, [--] engagements
"Learn how to advance your cancer research by accurately modeling the tumor microenvironment (TME) with Shawn Fahl and Meredith Osborn in this webinar hosted by Discovery Life Sciences. They will introduce a novel co-culture approach that integrates tumoroids with CAFs and immune cells overcoming the limitations of traditional models to achieve a true "patient in a dish" complexity. Register now to gain insights into this innovative method and accelerate next-generation oncology drug discovery and personalized medicine: #CancerResearch #TumorMicroenvironment #DrugDiscovery"
X Link 2025-12-10T11:07Z 26.1K followers, [--] engagements
"Medtronics Robert Kowal MD PhD from the Medtronic Cardiac and Vascular division discusses how their global HFpEF trial is advancing personalized pacing and integrating patient input equity and implementation science into its design. Read more at by @VeraKovacevic3. https://buff.ly/f2j1aoU https://buff.ly/f2j1aoU https://buff.ly/f2j1aoU https://buff.ly/f2j1aoU"
X Link 2025-12-12T11:05Z 26K followers, [--] engagements
"Dennis Grasela of @BMSNEWS shares how large-scale real-world evidence (RWE) programs are capturing insights from diverse patient populations and healthcare systems to strengthen evidence generation in obstructive hypertrophic cardiomyopathy (oHCM). Read more at by @VeraKovacevic3. https://buff.ly/wETKmCr https://buff.ly/wETKmCr"
X Link 2025-12-15T11:09Z 26.1K followers, [--] engagements
"The FDA is expanding how RWE can support medical device submissions. It will now accept deidentified patient data such as that from massive patient registries and EHRs as part of RWD in certain medical device submissions. Read more: #FDA #MedicalDevices #FDARegulaton #RWE #RealWorldEvidence #RealWorldData #EHRData #PatientRegistries https://buff.ly/ksIZoaz https://buff.ly/ksIZoaz https://buff.ly/ksIZoaz https://buff.ly/ksIZoaz"
X Link 2025-12-19T11:00Z 26.1K followers, [--] engagements
"2026 is shaping up to be a defining year for HEOR and market access. From RWEs growing role to AI-supported analyses and outcomes-based payment models heres how evidence and access strategies are evolving at by Soumya Shashikumar. #HEOR #MarketAccess #RealWorldEvidence #HealthEconomics #HealthcareTrends https://buff.ly/MNPWKJk https://buff.ly/MNPWKJk https://buff.ly/MNPWKJk https://buff.ly/MNPWKJk"
X Link 2025-12-26T11:30Z 26.1K followers, [--] engagements
"From rising cybersecurity and AI expectations to QMSRs [----] start medtech teams will have a clearer view of what regulators want next year. Explore key insights in our medical device regulations [----] blog at by @soumya2390. #MedicalDeviceRegulations #Medtech2026 #FDAUpdates #DigitalHealth #QualitySystems https://buff.ly/LNHmr0d https://buff.ly/LNHmr0d https://buff.ly/LNHmr0d https://buff.ly/LNHmr0d"
X Link 2025-12-30T11:30Z 26.1K followers, [--] engagements
"As Cervical Health Awareness Month [----] approaches new screening guidance global vaccination efforts and late-stage clinical trials point to where prevention and treatment are headed next. Learn more by @soumya2390 #CervicalHealthAwarenessMonth2026 #CervicalCancer #OncologyResearch #CancerPrevention https://buff.ly/bfhCsUT https://buff.ly/bfhCsUT https://buff.ly/bfhCsUT https://buff.ly/bfhCsUT"
X Link 2026-01-02T11:00Z 26.1K followers, [--] engagements
"Explore phase-appropriate strategies for bioassay method transfer with Jessica Weaver MRes Katie Harcher MS Julia Hecker PhD and Leigh Laundon PhD in our upcoming webinar hosted by BioAgilytix. Our experts will discuss how to mitigate variability caused by laboratory conditions and reagents while ensuring consistency across global sites through robust documentation and risk-based validation. Register now to learn how to align your processes with FDA and EMA guidance: #BioAgilytix #Bioassay #MethodTransfer #CMC #AssayValidation #RegulatoryCompliance #LifeSciences #DrugDevelopment"
X Link 2026-01-06T20:37Z 26.1K followers, [--] engagements
"The FDA has approved Cablivi for pediatric patients with the rare blood disorder acquired thrombotic thrombocytopenic purpura (aTTP) alongside plasma exchange and immunosuppressive therapy. Learn how the nanobody therapy works at by @soumya2390. #Sanofi #FDAApproval #aTTP #NanobodyTherapy #PediatricRareDisease https://buff.ly/VsyPNUZ https://buff.ly/VsyPNUZ https://buff.ly/VsyPNUZ https://buff.ly/VsyPNUZ"
X Link 2026-01-12T16:03Z 26K followers, [---] engagements
"The FDA has shared how it is applying flexibility to CMC requirements for cell and gene therapies spanning clinical development release specifications and process validation as programs move toward BLA review. Dive into our news brief by @soumya2390 at #FDA #CellAndGeneTherapy #CGTManufacturing #BiologicsRegulation #CMC https://buff.ly/bkMUdRa https://buff.ly/bkMUdRa https://buff.ly/bkMUdRa https://buff.ly/bkMUdRa"
X Link 2026-01-13T13:28Z 26K followers, [--] engagements
"Join us to explore how clinical in-use studies de-risk biotherapeutic development with Daniel Pettit and Natalia Harasimiuk in this insightful webinar hosted by FUJIFILM Biotechnologies. They will examine how stressors during preparation and administration impact therapy and share strategies to mitigate risks such as aggregation adsorption and functional loss through clinical mimic studies. Register now to learn how to design robust fit-for-purpose protocols that align with global regulatory expectations: #FUJIFILM #Biotherapeutics #ClinicalTrials #DrugProductDevelopment #InUseStudies"
X Link 2026-01-13T13:54Z 26K followers, [--] engagements
"GSK reported Phase III results for bepirovirsen in chronic hepatitis B showing higher functional cure rates vs. standard therapy. Dive into the clinical trial data trial design endpoints and more at by @soumya2390. #GSK #PhaseIII #HepatitisB #Bepirovirsen https://buff.ly/yLTuKaF https://buff.ly/yLTuKaF https://buff.ly/yLTuKaF https://buff.ly/yLTuKaF"
X Link 2026-01-13T15:30Z 26K followers, [---] engagements
"Eli Lillys oral GLP-1 orforglipron helped patients maintain weight loss after switching off injectable GLP-1s in a first-of-its-kind Phase III trial pointing to a potential pill-based option for long-term obesity management. Read more at #GLP1 #ClinicalTrials #WeightLossDrugs https://buff.ly/MOSGPlN https://buff.ly/MOSGPlN https://buff.ly/MOSGPlN https://buff.ly/MOSGPlN"
X Link 2026-01-14T14:43Z 26K followers, [--] engagements
"How personalized should patient engagement be in clinical trials @IQVIA_global's Stephanie Galarza shares how thoughtful standardized support can improve retention without compromising scientific integrity. Watch the Xtalks Spotlight and read the full article at by @VeraKovacevic3. #ClinicalTrials #PatientEngagement #PatientCentricity #ClinicalResearch #XtalksSpotlight #IQVIA https://buff.ly/NVLG2qE https://buff.ly/NVLG2qE"
X Link 2026-01-20T14:38Z 26K followers, [---] engagements
"Gain insights from Dr. Ian Brown from FUJIFILM Biotechnologies about key considerations for process characterization studies including feed material strategy small-scale model verification and data interpretation to support robust CMC submissions. Read more at #Bioprocessing #ProcessCharacterization #CMC #BiopharmaManufacturing https://buff.ly/DfIR6Pr https://buff.ly/DfIR6Pr"
X Link 2026-01-20T21:15Z 26K followers, [--] engagements
"The FDA has approved AstraZeneca-Daiichi Sankyos ADC Enhertu in combination with Roches Perjeta as a first-line treatment for unresectable or metastatic HER2-positive breast cancer marking the first new frontline option for this subset in more than a decade. Read more at https://buff.ly/rcHeINj https://buff.ly/rcHeINj"
X Link 2026-01-22T14:24Z 26K followers, [--] engagements
"Learn how to mitigate the risk of protocol deviations in patient enrollment with Catherine Tyner and Craig McLendon in our upcoming webinar hosted by AG Mednet. They will discuss applying a Quality by Design framework to eligibility review as emphasized in the latest FDA draft guidance to prevent costly delays and safeguard data integrity. Register now to explore how centralized workflows and structured eligibility decisions enable more consistent enrollment and reduce downstream operational risk for sponsors and CROs: #AGMednet #ClinicalTrials #PatientEnrollment #FDACompliance"
X Link 2026-01-22T14:40Z 26K followers, [--] engagements
"Join us to explore how integrated analytical tools advance RNA therapeutics with Todd Giardiello and Diana Cox PhD in this webinar hosted by Rockland Immunochemicals Inc. They will examine how sensitive antibody detection panels enable universal localization and quantification of oligonucleotides while next-generation sequencing maps direct RNA-target interactions across the transcriptome. Register now to learn how combining these complementary technologies can de-risk candidate selection and provide a comprehensive view of therapeutic performance and specificity: #RocklandImmunochemicals"
X Link 2026-01-22T14:44Z 26K followers, [--] engagements
"Which programs and platforms are drawing investor support in early [----] Our Biotech Funding Tracker highlights recent rounds across neurology immunology oncology and AI-driven drug discovery. Dive in at by @soumya2390. #BiotechFunding #LifeSciences #VentureCapital #DrugDevelopment #BiotechTrends https://buff.ly/fih4K7Z https://buff.ly/fih4K7Z https://buff.ly/fih4K7Z https://buff.ly/fih4K7Z"
X Link 2026-01-22T19:32Z 26K followers, [--] engagements
"Discover how to optimize cell-based vaccine production with Sara Bursomanno PhD and Chantale Julien in this insightful webinar hosted by Novo Nordisk Pharmatech. They will explore how animal-free recombinant insulin and trypsin improve viral yield and manufacturing efficiency while reducing contamination risks in common systems like Vero and HEK293 cells. Register now to learn how these high-purity reagents deliver enhanced safety and cost-effective production across diverse vaccine platforms: #NovoNordiskPharmatech #VaccineManufacturing #Bioprocessing #CellCulture #RecombinantInsulin"
X Link 2026-01-23T11:46Z 26K followers, [--] engagements
"Microbial-based biologics pose unique manufacturing challenges. Steve Loftus of FUJIFILM Biotechnologies explains why tailored iterative process development is critical to accelerating IND and early clinical timelines. Read more at #FUGIFILMBiotechnologies #Biologics #ProcessDevelopment #Biomanufacturing https://buff.ly/mH42vVi https://buff.ly/mH42vVi https://buff.ly/mH42vVi https://buff.ly/mH42vVi"
X Link 2026-01-26T15:33Z 26K followers, [--] engagements
"Explore the future of flexible biologics manufacturing with Charles Heise in this webinar hosted by FUJIFILM Biotechnologies. Our expert will examine how a globally harmonized CDMO model supports rapid technology transfer and how continuous processing strategies can be integrated into single-use facilities. Register now to learn how modular multi-product ecosystems and perfusion-ready cell lines improve supply chain resilience and help drug developers respond to shifting patient needs with agility: #FUJIFILM #Biomanufacturing #CDMO #Biologics #SupplyChain #ContinuousProcessing #TechTransfer"
X Link 2026-01-26T15:50Z 26K followers, [--] engagements
"Designing more effective meaningful trials for IPF and other rare respiratory diseases requires new thinking. Thermo Fisher Scientifics Francis Jones PhD shares the strategies redefining study design including biomarker-driven selection better patient engagement and technology-enabled data capture. Watch the video and read more at by @VeraKovacevic3. #ClinicalTrials #ClinicalResearch #RareDisease #RespiratoryDisease #IPF https://buff.ly/34xaS8B https://twitter.com/i/web/status/1999227666579308725 https://buff.ly/34xaS8B https://twitter.com/i/web/status/1999227666579308725"
X Link 2025-12-11T21:19Z 26K followers, [--] engagements
"With its Nasdaq debut Aktis Oncology is funding Phase Ib programs in urothelial and other solid tumors using targeted alpha radiopharmaceuticals. Read about its miniprotein platform and manufacturing plans at by @soumya2390. #Radiopharmaceuticals #AktisOncology #BiotechIPO https://buff.ly/xP7evHv https://buff.ly/xP7evHv https://buff.ly/xP7evHv https://buff.ly/xP7evHv"
X Link 2026-01-28T21:37Z 26K followers, [--] engagements
"Zepbounds latest TV commercial brings $299 self-pay into focus. Our article breaks down the ads message access options and recent clinical updates across Lillys obesity portfolio at by @soumya2390. #Zepbound #ObesityTreatment #GLP1 #PharmaAdvertising #WeightManagement https://buff.ly/4v8MsMt https://buff.ly/4v8MsMt https://buff.ly/4v8MsMt https://buff.ly/4v8MsMt"
X Link 2026-01-28T21:39Z 26K followers, [--] engagements
"The Gates Foundation and OpenAI have launched a $50M initiative to support the use of AI in primary care across Africa starting in Rwanda. We examine what Horizon1000 aims to do and how AI could support clinicians facing workforce shortages at by @soumya2390. #GatesFoundation #OpenAI #AfricaHealthcare #ArtificialIntelligence #PrimaryCare https://buff.ly/Ow2wvzk https://buff.ly/Ow2wvzk https://buff.ly/Ow2wvzk https://buff.ly/Ow2wvzk"
X Link 2026-01-29T11:42Z 26K followers, [--] engagements
"New Phase II data from Roche show sustained weight loss with CT-388 a dual-hormone therapy being studied for obesity. Read the full story at by @soumya2390. #Roche #CT388 #ObesityResearch #GLP1 #GIP https://buff.ly/PPMiMon https://buff.ly/PPMiMon"
X Link 2026-01-29T12:42Z 26K followers, [--] engagements
"Explore the transformative potential of in vivo CAR T-cell therapies with Juliana Campo Garcia in this technical webinar hosted by GenScript. She will examine how mRNA and lipid nanoparticle (LNP) technologies enable transient controlled CAR expression and targeted delivery directly to immune cells. Register now to gain insights into optimizing platform selection LNP formulation and analytical testing to overcome the common challenges of developing next-generation in vivo immunotherapies: #GenScript #CARTcellTherapy #mRNA #LNPs #InVivo #GeneTherapy #Immunotherapy #Biotech #DrugDelivery"
X Link 2026-01-29T14:29Z 26K followers, [--] engagements
"Learn how to deliver more with less through centralized FSP models with Suchela Srivatsa and Claire Rielly in this webinar by IQVIA. They will provide a practical stepwise playbook for modernizing clinical operations focusing on how to "right-shore" high-volume tasks like eTMF intake and site visit report reviews to standardize quality and reduce costs. Register now to explore how the framework improves inspection readiness and global oversight while maintaining full control over your data: #IQVIA #ClinicalOperations #FSP #ClinicalTrials #PharmaEfficiency #RightShoring #InspectionReadiness"
X Link 2026-01-30T14:40Z 26K followers, [--] engagements
"📰 Sagimet Biosciences' oral FASN inhibitor denifanstat is advancing to Phase III trials for MASH. The study set to start by year-end aims to enroll [----] patients. Read more at by @AyeshaR1202. https://buff.ly/3Avsb59 https://buff.ly/3Avsb59"
X Link 2024-11-06T14:03Z 26K followers, [---] engagements
"📰 Journey Medical has received FDA approval for its rosacea drug Emrosi. Read more at by @AyeshaR1202 about the drug and how Journey is hoping it could rival the current standard-of-care treatment for rosacea. #Rosacea #Dermatology https://buff.ly/3AwcwCJ https://buff.ly/3AwcwCJ"
X Link 2024-11-07T22:30Z 26K followers, [---] engagements
"Roche's $1.5B acquisition of Poseida Therapeutics is set to advance off-the-shelf CAR-T treatments. With scalable solutions patients battling cancers and autoimmune diseases could soon see faster accessible therapies. Learn more at by @soumya2390. https://buff.ly/3OwbU3i https://buff.ly/3OwbU3i"
X Link 2024-11-29T16:55Z 26K followers, [---] engagements
"In this episode hear about Intensity Therapeutics innovative intratumoral therapeutics currently in trials for soft tissue sarcoma and breast cancer from company founder chairman and CEO Lewis Bender. Listen now at 🎙 https://buff.ly/3Zxe7kd https://buff.ly/3Zxe7kd"
X Link 2024-12-13T15:45Z 26K followers, [---] engagements
"Neurocrine Biosciences Crenessity (crinecerfont) has been approved as the first new treatment in decades for the rare genetic disorder congenital adrenal hyperplasia (CAH). Read more at by @AyeshaR1202 about the approval. https://buff.ly/401RSnK https://buff.ly/401RSnK"
X Link 2024-12-18T21:30Z 26K followers, [---] engagements
"Aardvark Therapeutics IPO launches with $94.2M in capital fueling breakthrough research in hyperphagia and Prader-Willi syndrome. Learn more about Aardvarks next-gen pipeline for metabolic diseases at by @soumya2390. https://buff.ly/3XcgGb2 https://buff.ly/3XcgGb2"
X Link 2025-02-24T12:51Z 26K followers, [---] engagements
"✨ The 200th episode of the Xtalks Life Science Podcast is here Hear from Coya Therapeutics CEO Dr. Arun Swaminathan as he discusses the companys innovative immunotherapeutic approach to enhancing Treg function in diseases like ALS and Alzheimers at https://buff.ly/q2VMFwu https://buff.ly/q2VMFwu"
X Link 2025-03-19T13:49Z 26K followers, [---] engagements
"In this episode Unicycive Therapeutics founder and CEO Dr. Shalabh Gupta discusses the current unmet needs in kidney diseases and Unicycives innovative approaches to addressing them. Listen now at 🎙 https://buff.ly/J2LvFyw https://buff.ly/J2LvFyw"
X Link 2025-03-26T20:23Z 26K followers, [---] engagements
"Soleno Therapeutics Vykat XR received FDA approval for hyperphagia in patients with Prader-Willi syndrome (PWS). Read more at by @AyeshaR1202 about the treatment. https://buff.ly/1YK8NjX https://buff.ly/1YK8NjX"
X Link 2025-04-16T21:29Z 26K followers, [---] engagements
"Precision psychiatry is reshaping neuropsychiatric clinical trials. Alto Neurosciences Dr. Amit Etkin discusses how harnessing biomarkers EEG and wearables to tailor therapies can cut placebo noise and boost success. Read more in our Xtalks Clinical Edge feature at by @AyeshaR1202. https://buff.ly/CZRiP8C https://buff.ly/CZRiP8C"
X Link 2025-05-14T12:11Z 26K followers, [---] engagements
"Shoulder Innovations just raised $75M in its NYSE IPO to expand its AI-powered planning implant lineup & outpatient-friendly tools for shoulder surgery. Learn how this medtech debut supports arthroplasty innovation at by @soumya2390. #ShoulderInnovationsIPO #ShoulderSurgery #MedicalDevices #Orthopedics #Arthroplasty #IPO2025 #SurgicalInnovation #HealthcareInvesting #ReverseShoulder #AnatomicShoulder https://buff.ly/NsxUMa7 https://buff.ly/NsxUMa7 https://buff.ly/NsxUMa7 https://buff.ly/NsxUMa7"
X Link 2025-08-12T14:57Z 26K followers, [---] engagements
"🧬 How can you decode the tumor microenvironment to accelerate therapeutic discovery Join QIAGEN for a webinar with Kristin OMalley to explore how curated biological knowledge and predictive modeling tools can help translational scientists make sense of complex omics data. Learn how to construct molecular networks interpret gene expression datasets and predict immune and tumor behavior including insights from Interleukin1 beta in NSCLC. Register now: #TumorMicroenvironment #PredictiveModeling #TranslationalScience #QIAGEN #OncologyResearch https://buff.ly/C0Ookw4 https://buff.ly/C0Ookw4"
X Link 2025-09-22T10:21Z 26K followers, [---] engagements
"With $285M from its IPO LB Pharmaceuticals will fund new trials of its investigational drug LB-102 for schizophrenia and bipolar depression. Explore how this biopharma is advancing neuropsychiatry care at by @soumya2390. #LBPharmaceuticals #LBRX #LBPharmaIPO #Biotech #Neuropsychiatry #SchizophreniaResearch #BipolarDepression #ClinicalTrials #InvestigationalDrug https://buff.ly/hNn53j1 https://buff.ly/hNn53j1 https://buff.ly/hNn53j1 https://buff.ly/hNn53j1"
X Link 2025-10-24T14:26Z 26K followers, [--] engagements
"Novartis is making a $12B move into RNA therapeutics with the acquisition of Avidity Biosciences. The deal adds Aviditys RNA platform and late-stage programs for Duchenne DM1 and FSHD bolstering Novartiss neuromuscular disease pipeline. Read more at #RNAtherapeutics #DuchenneMuscularDystrophy #MergersAndAcquisitions #Novartis #AvidityBiosciences https://buff.ly/s99ur59 https://twitter.com/i/web/status/1985416691166175627 https://buff.ly/s99ur59 https://buff.ly/s99ur59 https://twitter.com/i/web/status/1985416691166175627 https://buff.ly/s99ur59"
X Link 2025-11-03T18:40Z 26K followers, [---] engagements
"Thermo Fisher Scientifics Francis Jones PhD shares how precision medicine meaningful endpoints and evolving technologies are influencing study design for IPF and other rare respiratory diseases. Watch the video and read more at by @VeraKovacevic3. #ClinicalTrials #ClinicalResearch #RareDisease #RespiratoryDisease #IPF https://buff.ly/34xaS8B https://twitter.com/i/web/status/2001628590350237821 https://buff.ly/34xaS8B https://buff.ly/34xaS8B https://twitter.com/i/web/status/2001628590350237821 https://buff.ly/34xaS8B"
X Link 2025-12-18T12:20Z 26K followers, [--] engagements
"Learn how to accelerate drug development through master protocol trial designs with Melanie Owen MS Susie Cain RAC and Song Wang in this webinar hosted by Thermo Fisher Scientific. They will explore how evaluating multiple investigational products under a single infrastructure streamlines coordination and provides the adaptive design flexibility needed to modify studies based on treatment performance. Register now to gain insights into implementing these complex clinical trials to improve decision-making and eliminate the need for redundant trial protocols: #ThermoFisherScientific #PPD"
X Link 2026-01-08T16:23Z 26K followers, [---] engagements
"Sarepta released new 3-year trial data examining long-term outcomes and safety for Elevidys in Duchenne muscular dystrophy (DMD) a rare childhood muscle disease. Read more about the clinical trial at by @soumya2390. #Elevidys #DuchenneMuscularDystrophy #GeneTherapy #RareDisease https://buff.ly/hOyeD9k https://buff.ly/hOyeD9k https://buff.ly/hOyeD9k https://buff.ly/hOyeD9k"
X Link 2026-01-30T19:14Z 26K followers, [---] engagements
"Evaluate how early protocol design decisions impact clinical supply strategy and RTSM performance with Jennifer Cobb Foulkes Jennifer Teti Savannah Holt and Jonathan Pritchard in this collaborative webinar hosted by 4G Clinical. They will examine how specific design choices from kit architecture and expiry strategy to pooling models and resupply logic directly shape trial execution and influence forecasting accuracy. Register now to learn how to bridge the gap between protocol intent and operational readiness while exploring how emerging AI technologies are transforming the future of supply"
X Link 2026-02-02T14:25Z 26K followers, [--] engagements
"Each biologic has its own unique formulation challenges. Madison White Senior Scientist at FUJIFILM Biotechnologies discusses how a structured data-rich formulation approach can help de-risk development and support preclinical readiness. Read more at #Biologics #Formulation #Biotech #FUJIFILMBiotechnologies https://buff.ly/TpDjs4Y https://buff.ly/TpDjs4Y https://buff.ly/TpDjs4Y https://buff.ly/TpDjs4Y"
X Link 2026-02-02T14:26Z 26K followers, [--] engagements
"In this episode hear Domp Chief Development Officer Dr. Ahmed Enayetallah discuss innovative therapeutic approaches based on nerve growth factor (NGF) biology in ocular diseases with high unmet need such as NAION. Listen now at 🎙 https://buff.ly/QIjM0Nr https://buff.ly/QIjM0Nr"
X Link 2026-02-04T20:40Z 26K followers, [--] engagements
"Explore how community-based trial models prioritize the patient experience with Deon Miller DO Nancy Lizzul and Lou Cappoli in this webinar hosted by EmVenio Clinical Research. They will share real-world data on how localized engagement strategies including community-site networks and mobile research units overcome traditional barriers to improve enrollment and retention. Register now to learn how these models strengthen patient trust and provide the key metrics needed to advance health equity and inclusivity across diverse therapeutic areas: #EmVenio #ClinicalResearch #CommunityBasedResearch"
X Link 2026-02-05T11:19Z 26K followers, [--] engagements
"The FDA has issued a complete response letter for AstraZenecas subcutaneous anifrolumab in systemic lupus erythematosus (SLE). Heres what the decision means and what comes next at by @soumya2390. #FDA #SystemicLupusErythematosus #LupusResearch #Biologics #DrugRegulation https://buff.ly/xboxnic https://buff.ly/xboxnic https://buff.ly/xboxnic https://buff.ly/xboxnic"
X Link 2026-02-05T17:08Z 26K followers, [--] engagements
"Navigate the complexities of site selection in rare disease research with Paula Orandash and Benjamen Varsano in this strategic webinar hosted by Ergomed. They will demonstrate how a "three-pillar" landscape analysis uncovers critical insights that traditional historical data often misses. Register now to learn how early investment in patient-centric intelligence and real-world treatment patterns can shorten timelines improve recruitment feasibility and ensure more ethical study designs: #Ergomed #RareDisease #ClinicalTrials #LandscapeAnalysis #PatientEngagement #SiteSelection"
X Link 2026-02-06T11:24Z 26K followers, [--] engagements
"The US Food and Drug Administration (FDA) has approved Luye Pharmas Rykindo for the treatment of #schizophrenia and as a monotherapy or adjunctive #therapy for the maintenance treatment of #bipolardisorder in adults. Read more on this story here: https://buff.ly/3HDuG64 https://buff.ly/3HDuG64"
X Link 2023-01-29T17:00Z 26K followers, [---] engagements
"In this episode Xtalks interviews two experts from CytoMed Therapeutics Mr. Choo Chee Kong & Dr. Tan Wee Kiat about the companys mission to develop more affordable #cellular #cancer therapies the launch of the companys new IPO & more. Listen here: https://buff.ly/3PNLZWJ https://buff.ly/3PNLZWJ"
X Link 2023-07-09T15:30Z 26K followers, [---] engagements
"We spoke with Dr. Taylor H. Schreiber CEO and Co-Founder of Shattuck Labs about the companys pioneering approach to developing dual-function fusion proteins for the treatment of #cancer and #autoimmunediseases. Read more by @VeraKovacevic3: #Biologics https://buff.ly/3Pv7E5h https://buff.ly/3Pv7E5h"
X Link 2024-03-05T15:04Z 26K followers, [---] engagements
"The complexity of biological systems poses challenges in drug discovery. Join our virtual event by Akoya Biosciences to learn how advancements in spatial biology can optimize therapeutic development: #SpatialBiology #DrugDiscovery #Webinar https://buff.ly/4enxBxe https://buff.ly/4enxBxe"
X Link 2024-11-11T15:30Z 26K followers, [---] engagements
"Jupiter Neurosciences launches its $11M IPO on Nasdaq aiming to advance its investigational drug Jotrol a resveratrol-based innovation targeting CNS disorders like Parkinsons and Alzheimers. Explore their platform and partnerships at by @soumya2390. https://buff.ly/3ZgDnem https://buff.ly/3ZgDnem"
X Link 2024-12-05T14:11Z 26K followers, [---] engagements
"Maze Therapeutics has arrived with its IPO offering bringing with it genetically targeted treatments aimed at APOL1-mediated kidney disease. Learn more at by @soumya2390. https://buff.ly/3CBtdO9 https://buff.ly/3CBtdO9"
X Link 2025-02-04T21:16Z 26K followers, [---] engagements
"Beta Bionics has successfully raised $234.6 million from its IPO which will fund the commercialization and clinical trials of its flagship product the iLet bionic pancreas system. Learn more about the insulin dosing management system at by @soumya2390. https://buff.ly/3Qd3uPb https://buff.ly/3Qd3uPb"
X Link 2025-02-11T14:30Z 26K followers, [---] engagements
"Sionna Therapeutics IPO has arrived in the cystic fibrosis landscape. Leveraging innovative NBD1 stabilizers its lead candidates SION-719 and SION-451 are currently in Phase I trials targeting the critical F508del mutation. More at by @soumya2390. https://buff.ly/4ia0IGw https://buff.ly/4ia0IGw"
X Link 2025-02-21T17:30Z 26K followers, [---] engagements
"Kestra Medical Technologies IPO raises $202M bolstering its wearable cardioverter defibrillator and digital health platform. Learn more about Kestra at by @soumya2390. https://buff.ly/4wvzVKX https://buff.ly/4wvzVKX"
X Link 2025-03-17T13:44Z 26K followers, [---] engagements
"In this episode Vera Therapeutics founder and CEO Dr. Marshall Fordyce discusses the current landscape of autoimmune diseases and how his company is innovating treatments for IgA nephropathy. Listen now at 🎙 https://buff.ly/PxDYf0L https://buff.ly/PxDYf0L"
X Link 2025-04-03T19:39Z 26K followers, [---] engagements
"Hinge Health IPO debuts at $437.3M merging AI wearables and human care to advance musculoskeletal health. Explore how their FDA-cleared Enso device and TrueMotion tech aim to reshape pain care at by @soumya2390. https://buff.ly/gEYhbwQ https://buff.ly/gEYhbwQ"
X Link 2025-05-29T20:56Z 26K followers, [---] engagements
"❓ How can we avoid hidden pitfalls in bioinformatics workflows Join Bullfrog AIs webinar with Juan Felipe Beltrn to explore common issues in AI-powered computational biology workflows including mismanaging compositional data overinterpreting ML feature importance and misapplying generative AI for ranking tasks. Register now: #Bioinformatics #MachineLearning #AIinBioinformatics #DrugDiscovery #BioinformaticsChallenges #BullfrogAI https://buff.ly/xzyNeGx https://twitter.com/i/web/status/1931020102456975686 https://buff.ly/xzyNeGx https://twitter.com/i/web/status/1931020102456975686"
X Link 2025-06-06T16:07Z 26K followers, [---] engagements
"The Omada Health IPO is official. The company raised $120M to expand its digital programs for musculoskeletal diabetes and GLP-1 support. We explore whats next for Omada and what the filing reveals at by @soumya2390. https://buff.ly/bD2KZjo https://buff.ly/bD2KZjo"
X Link 2025-06-20T20:25Z 26K followers, [---] engagements
"Dr. Marshall Fordyce Founder and CEO of @Official_VeraTx shares how a science-first strategy is driving progress in IgA nephropathy (IgAN) and beyond. From designing rigorous trials to embedding patient and physician voices at every step Vera Therapeutics is redefining what it means to develop targeted patient-centered therapies. Read the full story in this Xtalks Clinical Edge interview at by Mohammad Ali. #AutoimmuneDiseases #IgAN #KidneyHealth #CKD #ClinicalResearch #DrugDevelopment #PatientCentricity #LifeSciences #Biotech #Pharma #XtalksClinicalEdge https://buff.ly/ElYX32u"
X Link 2025-08-27T16:40Z 26K followers, [---] engagements
"❓ How can you turn messy clinical PDFs into analysis-ready datasets without losing human oversight Join BullFrog AIs webinar with Juan Felipe Beltrn Lacouture PhD to learn how bfPREPTM and bfLEAPTM streamline clinical data intake entity resolution and OMOP structuring. Discover practical templates agent-powered workflows and verified automation strategies that preserve human judgment while accelerating analysis-ready outputs. Register now: #ClinicalData #DataAutomation #OMOP #MachineLearning #BullFrogAI #AgenticAI https://buff.ly/xvx6klK https://twitter.com/i/web/status/1971571748760879542"
X Link 2025-09-26T13:45Z 26K followers, [---] engagements
"MapLight Therapeutics IPO raised around $296M to fund Phase II trials of its muscarinic-based therapy for schizophrenia and Alzheimers psychosis. Learn how this clinical-stage biotech is advancing CNS drug discovery at by @soumya2390. #MapLightTherapeutics #BiotechIPO #CNS #DrugDiscovery #Neuroscience https://buff.ly/vuGdJxZ https://buff.ly/vuGdJxZ https://buff.ly/vuGdJxZ https://buff.ly/vuGdJxZ"
X Link 2025-11-03T19:42Z 26K followers, [---] engagements
"Bausch + Lombs campaign for dry eye disease treatment Miebo features American sportscaster Erin Andrews with an ad spot showing her battling gritty eyes and at pop ups in New York. Read more at #DryEyeDisease #Bausch+Lomb https://buff.ly/Mwj4Mcv https://buff.ly/Mwj4Mcv"
X Link 2025-11-06T15:30Z 26K followers, [---] engagements
"Structure Therapeutics reported positive Phase II data for its oral GLP-1 agonist aleniglipron in adults with obesity or overweight. The results support plans for Phase III development. Dive into the clinical trial data at by @soumya2390. #StructureTherapeutics #ClinicalTrials #ObesityResearch #GLP1 #Aleniglipron https://buff.ly/DxWvAuR https://buff.ly/DxWvAuR"
X Link 2025-12-15T16:28Z 26K followers, [--] engagements
"Eli Lillys next-generation obesity drug #retatrutide outperformed its current blockbuster Zepbound in a late-stage trial delivering greater weight loss and easing knee pain in patients with osteoarthritis. Read more: #EliLilly #ClinicalTrials #ObesityDrugs #WeightLossDrugs #GLP1Drugs #Zepbound https://twitter.com/i/web/status/2001819808992550942 https://buff.ly/xfUq30t https://twitter.com/i/web/status/2001819808992550942 https://buff.ly/xfUq30t"
X Link 2025-12-19T01:00Z 26K followers, [---] engagements
".@EliLillyandCo announces its roster of Team USA athletes for Milano Cortina [----] and pledges to turn Olympic and Paralympic milestones into meaningful community impact. Every medal earned will support US nonprofits improving health access: #EliLilly #TeamUSA #MilanoCortina2026 #HealthEquity #CommunityHealth #Olympics #Paralympics #Lilly https://buff.ly/2Fu0w8U https://twitter.com/i/web/status/2008205188457238656 https://buff.ly/2Fu0w8U https://buff.ly/2Fu0w8U https://twitter.com/i/web/status/2008205188457238656 https://buff.ly/2Fu0w8U"
X Link 2026-01-05T15:53Z 26K followers, [--] engagements
"Cytokinetics has won FDA approval for Myqorzo (aficamten) for the treatment of symptomatic obstructive hypertrophic cardiomyopathy (oHCM) marking the companys first commercial product and its entry into a market led by Bristol Myers Squibbs Camzyos. Read more at #HCM #Cardiomyopathy #Myqorzo #Cytokinetics #FDAApproval https://buff.ly/1QfAGnX https://buff.ly/1QfAGnX"
X Link 2026-01-26T15:34Z 26K followers, [----] engagements
"Explore how organizations can achieve local compliance on a global scale with Jay Gandecha and Ana Pedro Jesuno in this strategic webinar hosted by IQVIA. They will discuss the benefits of integrating Local Qualified Person for Pharmacovigilance (LQPPV) responsibilities with comprehensive Lifecycle Management (LCM) to create unified governance and reduce operational duplication across the enterprise. Register now to discover how applied AI and adaptive resourcing models can allow sponsors to maintain high compliance standards across complex multi-country environments without being locked into"
X Link 2026-02-11T14:37Z 26K followers, [--] engagements
"In this episode INmune Bio CEO David Moss discusses targeting innate immunity therapeutically in diseases driven by chronic inflammation from the rare genetic disease RDEB to Alzheimers. Listen now at 🎙 https://buff.ly/Tze1NQm https://buff.ly/Tze1NQm"
X Link 2026-02-11T21:49Z 26K followers, [--] engagements
"Medtech layoffs in early [----] are affecting both device manufacturers and diagnostics companies with workforce reductions tied to site closures restructuring and contract changes. See whos getting affected at by @soumya2390. #MedtechLayoffs #MedicalDevices #MedtechIndustry #Diagnostics #Manufacturing https://buff.ly/SWcQVVQ https://buff.ly/SWcQVVQ"
X Link 2026-02-12T20:37Z 26K followers, [--] engagements
"Karuna Therapeutics revealed Phase III EMERGENT-2 trial results for their investigational drug KarXT in #schizophrenia published in The Lancet. Read more about the clinical trial data at #ClinicalResearch #Psychiatry #NeuroscienceClinicalTrials https://buff.ly/3NXilNd https://buff.ly/3NXilNd"
X Link 2023-12-26T11:30Z 26K followers, [---] engagements
"Caris Life Sciences is building an AI-led diagnostics and oncology drug discovery engine backed by $494M from its [----] IPO. Our article by @soumya2390 at walks through the companys tools partnerships and where it's headed. https://buff.ly/dHgVmrQ https://buff.ly/dHgVmrQ"
X Link 2025-06-25T20:17Z 26K followers, [---] engagements
"Who employs the most in pharma and healthcare 🌍 From biotech titans and legacy pharma to retail pharmacy giants and global CROs workforce size tells a powerful story of influence scale and global reach. 🔹 CVS Health and Walgreens Boots Alliance top the list not for R&D but for their vast retail and insurance operations. 🔹Johnson & Johnson Pfizer Roche and AstraZeneca remain R&D powerhouses with global commercial infrastructure. 🔹Sinopharm and CR Pharma companies based in China are rapidly scaling. 🔹Europe continues to lead with Sanofi Novo Nordisk Bayer and Novartis maintaining large"
X Link 2025-08-15T19:43Z 26K followers, [---] engagements
"Ivonescimab delivers survival benefits in EGFR-mutant NSCLC. Final trial data from China show improved PFS and OS with ivonescimab + chemo vs chemo alone. Makers Akeso and Summit Therapeutics plan to submit a BLA in Q4 [----]. Read more at #Ivonescimab #LungCancer #NSCLC #Oncology #Akeso #ClinicalTrials https://buff.ly/hTbgwUr https://buff.ly/hTbgwUr"
X Link 2025-12-01T14:22Z 26K followers, [---] engagements
"Explore how to accelerate the transition from First-in-Human (FIH) to Proof-of-Concept (POC) with Aatir Butt in this webinar hosted by Fortrea. Our expert will discuss how adaptive study designs can eliminate "white space" between milestones enabling sponsors to respond dynamically to emerging data and streamline decision-making. Register now to learn how strategic site selection can enhance operational delivery and support the complex protocols of Phase I/Ib trials: #Fortrea #ClinicalTrials #EarlyPhase #PhaseI #DrugDevelopment #AdaptiveDesign #FirstInHuman #ProofOfConcept #Biotech"
X Link 2026-02-13T11:44Z 26K followers, [--] engagements
"In this episode hear from Kairos Pharmas CEO Dr. Yu about the companys focus on developing therapeutics that counter cancer drug resistance. Listen now at 🎙 https://buff.ly/3ZfGinq https://buff.ly/3ZfGinq"
X Link 2024-12-05T21:37Z 26K followers, [---] engagements
"Zhengye Biotechnologys IPO positions the company for rapid growth in the global veterinary vaccine market. With $6M raised Zhengye plans to expand its vaccine portfolio enhancing animal health worldwide. Learn more at by @soumya2390. https://buff.ly/4j6091A https://buff.ly/4j6091A"
X Link 2025-01-13T19:01Z 26K followers, [---] engagements
"Ascentage Pharma's IPO brings a new wave of targeted therapies such as olverembatinib and lisaftoclax for hematological cancers. Learn more about the companys innovative approach at by @soumya2390. https://buff.ly/42wPaZp https://buff.ly/42wPaZp"
X Link 2025-01-28T19:50Z 26K followers, [---] engagements
"Advanced Biomeds IPO raised $6.56M fueling innovative liquid biopsy testing for early cancer detection. Discover how their microfluidic platform could advance cancer diagnostics for better patient outcomes at by @soumya2390. https://buff.ly/hR80rJD https://buff.ly/hR80rJD"
X Link 2025-03-17T19:46Z 26K followers, [---] engagements
"Cuprina Holdings IPO raises $12M to fund bio-dressings for diabetic foot venous leg and pressure ulcers powered by maggot therapy and collagen from bullfrog-skin waste. Learn more about the IPO at by @soumya2390. https://buff.ly/oevHRsi https://buff.ly/oevHRsi"
X Link 2025-04-16T18:32Z 26K followers, [---] engagements
"Apimeds Pharmaceuticals US IPO brings a fresh angle to drug development: intradermal bee venom delivery. With plans for a new Phase III trial learn more about this unique approach at by @soumya2390. https://buff.ly/BkYT02e https://buff.ly/BkYT02e"
X Link 2025-05-21T20:23Z 26K followers, [---] engagements
"Picard Medical IPO raises $19.55M on NYSE American. Parent of SynCardia the company develops the only FDA- and Health Canada-approved total artificial heart. Learn what this means for patients at by @soumya2390. #PicardMedicalIPO #PicardMedical #SynCardia #ArtificialHeart #MedicalDevices #HeartFailure #BiventricularFailure #CardiacCare #MedTech #Cardiology #MedicalTechnology https://buff.ly/3YrNn7D https://buff.ly/3YrNn7D"
X Link 2025-09-19T16:39Z 26K followers, [---] engagements
"FDA approves Vizz (aceclidine eye drops) for presbyopia a non-surgical option for adults with age-related near vision loss. Learn how LENZ Therapeutics once-daily drop restores focus for up to [--] hours at by @soumya2390. #Vizz #Aceclidine #LENZTherapeutics #FDAApproval #Presbyopia #EyeCare #Ophthalmology #VisionHealth #PharmaNews #DrugDevelopment #EyeDrops #AgeRelatedVisionLoss #HealthcareNews #LifeSciences #EyeTreatment #FDA #PrescriptionDrugs https://buff.ly/PCIMwGo https://buff.ly/PCIMwGo"
X Link 2025-10-20T20:42Z 26K followers, [---] engagements
"Medtronics MiniMed Go smart multiple daily injection (MDI) system has received the green light from the FDA. Integrated with Abbotts Instinct sensor it offers personalized automated insulin delivery. Read more at #Diabetes #CGM #Medtronic #MiniMed https://buff.ly/F1eFbaX https://buff.ly/F1eFbaX"
X Link 2026-01-22T15:30Z 26K followers, [--] engagements
"The 7th issue of Xtalks Clinical Edge is here A special thanks to our front-cover interviewee Martin Beck Boehringer Ingelheim for sharing insights on improving awareness and patient-centered research in idiopathic pulmonary fibrosis. See more for [--] in-depth conversations with leaders advancing clinical research across therapeutic areas: 🧬 Immunology & Inflammatory Disease Paul F. Lizzul MD PhD MPH MBA AnaptysBio Niels Riedemann MD PhD InflaRx 👩🔬 Respiratory Research Martin Beck Boehringer Ingelheim Barry Quart PharmD Connect Biopharma 🧠 Neurology Ophthalmology & Ischemic Disease Ahmed"
X Link 2026-02-12T14:24Z 26K followers, [---] engagements
"Unlock high-value insights in early-phase oncology trials with Todd Rudo MD Anu Bansal MD MS Robert Kleiman MD and Kelly Dumais PhD in this webinar hosted by Clario. They will examine how advanced image analysis and concentration-effect modeling for cardiac safety are delivering deeper more sensitive data than traditional strategies. Register now to learn how integrating early patient-reported endpoints and pharmacokinetics can strengthen clinician assessments and support rapid evidence-based dose selection: #Clario #Oncology #EarlyPhase #ClinicalTrials #MedicalImaging #CardiacSafety #eCOA"
X Link 2026-02-12T14:37Z 26K followers, [--] engagements
"Healthcare layoffs continue into [----] as hospitals payers and healthcare services organizations adjust staffing amid funding and cost pressures. See the roundup at by @soumya2390. #HealthcareLayoffs #HealthcareWorkforce #Hospitals #HealthInsurance #Medicaid #HealthcareNews https://buff.ly/D9uaXZC https://buff.ly/D9uaXZC"
X Link 2026-02-12T18:36Z 26K followers, [--] engagements
"Pharma touched down at [----] Super Bowl LX with drugmakers like Novartis Novo Nordisk and Boehringer Ingelheim using the Big Game to spotlight disease screening GLP-1 weight-loss drugs and more. Read more at #SuperBowlLX #PharmaAds #HealthAwareness https://buff.ly/gNZ5Oyj https://buff.ly/gNZ5Oyj"
X Link 2026-02-12T19:33Z 26K followers, [--] engagements
"AstraZenecas $1.2B agreement with CSPC spans eight obesity and type [--] diabetes programs and includes AI-enabled peptide discovery and once-monthly dosing technology. Heres more on the AstraZeneca-CSPC Pharma deal by @soumya2390 at #AstraZeneca #Obesity #Type2Diabetes #GLP1 #DrugDevelopment #Biopharma https://buff.ly/KDuIAqC https://buff.ly/KDuIAqC"
X Link 2026-02-12T21:38Z 26K followers, [--] engagements
"From R&D centers to manufacturing sites AstraZenecas $15B China investment details how the company plans to scale development and production through [----]. Heres a closer look at the AstraZeneca China investment at by @soumya2390 . #AstraZeneca #ChinaInvestment #DrugDevelopment #Biopharma #LifeSciences https://buff.ly/AsAhVKv https://buff.ly/AsAhVKv"
X Link 2026-02-13T14:56Z 26K followers, [--] engagements
"🔁 Friday Rewind with Xtalks Heres a quick catch-up on what crossed our radar this past week. Read about new partnerships investment plans an FDA-cleared at-home cancer treatment device and updated trackers on layoffs and deal activity. 🤝 AstraZeneca Partners with CSPC in a $1.2B Obesity and Metabolic Disease Deal Read the deal details: 💰 AstraZenecas $15B China Plan: More R&D and Manufacturing Through [----] See whats included: 🩺 FDA Clears Optune Pax for At-Home Treatment of Pancreatic Cancer Get the clearance update: 🏥 Healthcare Layoffs 2026: Track Current Job Cuts Browse the latest"
X Link 2026-02-13T20:09Z 26K followers, [--] engagements
"Thinking About #Healthcare Startups Here Are [--] Things You Need to Know There has never been a better time to be a motivated entrepreneur looking to launch their own healthcare startup. But getting started takes more than a bright idea and seed funding. https://buff.ly/2u6IIql https://buff.ly/2u6IIql"
X Link 2019-06-14T16:00Z 27.1K followers, [--] engagements
"What were going to see in the future is a lot more decision making and knowledge based upon types of data analytics and data acquisition thats being undertaken says @CluePoints Patrick Hughes on the future of #clinicaltrials at #DIA2019"
X Link 2019-06-24T20:34Z 27.1K followers, [--] engagements
"Interactive Response Technology manages #clinicaltrial randomization and getting the right investigational product (IP) to the right #patient at the right time. But what happens when trials do not mature as expected Sign up to find out from @bioclinica https://buff.ly/3hvKIBQ https://buff.ly/3hvKIBQ"
X Link 2021-09-23T18:30Z 26.7K followers, [--] engagements
"Biohaven Pharmaceutical announced positive results from a Phase III trial evaluating the intranasal CGRP receptor antagonist #Zavegepant for the acute treatment of #migraine headaches. Read more by @AyeshaR1202. https://buff.ly/3ER7Xju https://buff.ly/3ER7Xju"
X Link 2021-12-10T22:30Z 26.2K followers, [--] engagements
"In this previous podcast episode the editorial team discussed the encouraging growth seen in recent years in #raredisease clinical research and also talked about the underrepresentation of Black people in #clinicaltrials. Listen now to learn more https://buff.ly/3HXO7n8 https://buff.ly/3HXO7n8"
X Link 2022-04-07T18:30Z 27.1K followers, [--] engagements
"Hear about the shortage of GLP-1 diabetes drug Ozempic and the offering of free insulin by a fake Eli Lilly Twitter account. Listen now: #Insulin #Diabetes #EliLilly #NovoNordisk #Type2Diabetes https://buff.ly/3gnnMY2 https://buff.ly/3gnnMY2"
X Link 2022-11-20T17:00Z 26.8K followers, [--] engagements
"The FDA has approved Acadia Pharmaceuticals Daybue (trofinetide) as the first and only treatment for Rett syndrome a rare complex neurodevelopmental disorder that mainly affects girls. Read more here. #RareDisease #FDA #NeurologicalDisorder https://buff.ly/4025FbC https://buff.ly/4025FbC"
X Link 2023-04-10T03:00Z 26.2K followers, [---] engagements
"Allergan Aesthetics an @AbbVie company received FDA approval for a new skin product called SkinVive by Juvderm. To learn how SkinVive works and what its used for read more by Vincent Xie. #SkinCare #Dermatology #MedicalAesthetics"
X Link 2023-05-24T16:03Z 27.4K followers, [--] engagements
"Recently @abbvies Epkinly received #FDA approval for relapsed or refractory diffuse large B-cell #lymphoma (#DLBCL) in adult patients who have undergone at least two prior lines of therapy. Read more about the drug and rivals from @AyeshaR1202"
X Link 2023-05-26T15:30Z 27.4K followers, [--] engagements
"The FDA approved BioMarin Pharmaceutical's (BMRN.O) #genetherapy for severe hemophilia A the company said giving patients with the inherited bleeding disorder an alternative to regular injections of missing #bloodproteins. https://buff.ly/3CP9TcR https://buff.ly/3CP9TcR"
X Link 2023-07-05T00:00Z 26.2K followers, [---] engagements
"Pfizer recently launched a new TV commercial for its migraine medication Nurtec ODT featuring Grammy-winning artist Lady Gaga as the face of the campaign. #PharmaTVAds #Headache #Pfizer #Migraine #PharmaceuticalMarketing"
X Link 2023-07-11T14:31Z 27.4K followers, [---] engagements
"California-based @TarsusRx has secured FDA approval for its drug Xdemvy to treat Demodex blepharitis. Read more to learn how Xdemvy addresses the root cause of this widespread inflammatory eye condition. #FDA #EyeHealth #EyeDrops #Ophthalmology https://buff.ly/3E8NLed https://buff.ly/3E8NLed"
X Link 2023-08-09T21:30Z 26.2K followers, [---] engagements
"California-based Tarsus Pharmaceuticals Inc. a leader in developing #therapeutic solutions for common diseases with limited treatment alternatives has secured approval from the US #FDA for its #drug #Xdemvy. https://buff.ly/3E8NLed https://buff.ly/3E8NLed"
X Link 2023-08-18T14:30Z 26.2K followers, [---] engagements
"🔬 Exciting collaboration ICON plc is teaming up with the US Biomedical Advanced Research and Development Authority (BARDA) to conduct a clinical trial assessing the efficacy of next-gen #COVID19 #vaccines. https://buff.ly/468PlZb https://buff.ly/468PlZb"
X Link 2023-09-15T00:00Z 27.1K followers, [---] engagements
"Exciting news in healthcare @SmithRx_PBM partners with TheracosBio to improve patient access to the latest type [--] diabetes medication Brenzavvy via the Mark Cuban Cost Plus Drug Company platform Read more at by @dc_chandel15. #Diabetes #Type2Diabetes"
X Link 2023-09-21T10:00Z 27.4K followers, [---] engagements
"Gain insights from @Onchip_Bio_en into cell-free riboswitches their creation through microfluidic droplet sorting and their significance in facilitating intercellular communication. #GeneticEngineering #Genomics #RNA #Proteomics"
X Link 2023-09-28T14:30Z 27.4K followers, [---] engagements
"Join our enlightening webinar with @EmvenioResearch on leveraging tailored and scalable solutions for community engagement in clinical trials. 🌟 Register to learn more about how customized and scalable solutions can advance community engagement:"
X Link 2023-10-03T17:30Z 27.5K followers, [---] engagements
"AbbVie led pharma ad spending in August with three of its drugs taking the top spots. Read more about the top ten leading pharma TV ad spenders in August at by @AyeshaR1202"
X Link 2023-10-04T10:00Z 27.4K followers, [---] engagements
"🌟 Secure your spot in this webinar with @Avantor_News on lab inventory management digitization Learn about digital solutions that can help mitigate the challenges of modern-day lab inventory management to optimize and scale #LabOperations Register here:"
X Link 2023-10-06T17:30Z 27.4K followers, [---] engagements
"🌐 Join our upcoming webinar that delves into weight loss in the context of #MetabolicDisease and its connection to cutting-edge imaging technology. 🔍 Learn about #WeightLoss and the pivotal role of imaging in understanding metabolic disease: #PET"
X Link 2023-10-09T14:30Z 27.4K followers, [---] engagements
"💻 Join @OpenClinica for their upcoming webinar to learn how to realize long-term success with EHR eSource and real-world data across traditional decentralized virtual and digital-first clinical trials. 🚀 Register here: #ClinicalTrials #EDC #eSource"
X Link 2023-10-09T16:00Z 27.4K followers, [---] engagements
"Join our upcoming webinar with @PPDCRO to learn about EU & US #pharmacovigilance requirements for risk management in drug development. 🌐 We'll cover it all from identification to reporting 📢 Register here: #PatientSafety #PharmaceuticalRegulation"
X Link 2023-10-10T16:04Z 27.4K followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing